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1. Summary 
Pancreatitis is a severe inflammatory disease that causes significant morbidity and mortality. 
It is currently considered a major risk factor for the development of pancreatic cancer. Acinar 
cells of the pancreas play an essential role in the initiation of pancreatitis. These cells secrete 
a variety of digestive enzymes normally in the inactive form (zymogens) to prevent digestion 
of the pancreas. However, it is now well documented that aberrant secretion and premature 
activation of zymogens cause cellular damage which triggers the significant inflammatory 
response characteristic of pancreatitis. Once the disease is initiated, regenerative and repair 
mechanisms in the pancreas are often unable to restore organ function, leading to organ 
failure and systemic complications. Causal treatments for pancreatitis are not yet available, 
thus the current therapeutic interventions aim to relieve pain and to prevent inflammatory 
relapses. The lack of effective strategies is partially linked to the incomplete understanding of 
the etiology and pathophysiology of pancreatitis.  
In this research project we aimed to investigate the potential signaling pathways underlying 
both the aberrant enzymatic secretion that initiates the disease, as well as the two main 
regenerative processes observed in the pancreas, namely progenitor-cell based regeneration 
and clonal proliferation.  
Using a genetically modified mouse model and pharmacological intervention in order to 
modulate serotonin (5-HT) levels in vivo, we demonstrated that the potent bioactive molecule 
5-HT regulates zymogen secretion by affecting acinar cell actin-cytoskeleton dynamics. 
Furthermore, we demonstrated the contribution of 5-HT to the regulation of pro-inflammatory 
mediators and the subsequent progression of the inflammatory response.  
We have also found that 5-HT regulates acinar cell regeneration according to a progenitor-
cell based reprogramming but not by clonal proliferation. In particular, we could prove that 5-
HT signaling is required for regeneration of acinar cells due to inflammation-mediated cellular 
injury. In contrast, 5-HT does not contribute to cell proliferation following partial 
pancreatectomy or mitogenic stimulation. 
 
Significance of the project: 
The results of this research show a substantial contribution of 5-HT in the etiopathogenesis 
of pancreatitis. In particular, we demonstrated that 5-HT promotes pancreatic zymogen 
secretion, immune cell recruitment and tissue regeneration. Further characterization of 5-HT 
mediated mechanisms at the molecular level will provide new insights for the management of 
pancreatitis, possibly limiting pancreatic injury while supporting tissue regeneration.  
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2. Zusammenfassung 
Pankreatitis ist eine schwere entzündliche Krankheit mit hoher Morbidität und Mortalität. Sie 
wird zurzeit als wichtiger Risikofaktor für die Entstehung eines Pankreaskarzinoms 
angesehen. Die Azinuszellen des exokrinen Pankreas spielen eine entscheidende Rolle bei 
der Entstehung von Pankreatitis. Diese Zellen sezernieren eine Vielzahl von 
Verdauungsenzymen. Um das Pankreas nicht zu verdauen, werden diese Enzyme jedoch 
normalerweise in einer inaktiven Form (Zymogen) sezerniert. Trotz dieses 
Schutzmechanismus konnte gezeigt werden, dass abnormale Sekretion und frühzeitige 
Aktivierung der Zymogene vorkommen kann und  Zellschäden verursacht. Die Schäden 
lösen darauf eine starke entzündliche Reaktion aus, die typisch für eine Pankreatitis ist. Hat 
die Krankheit einmal begonnen, sind die regenerativen Prozesse und 
Reparaturmechanismen des Pankreas oft nicht ausreichend,  um die Organfunktion wieder 
vollständig herzustellen. Dies kann zu Organversagen und systemischen Reaktionen führen. 
Bis heute sind keine ursächlichen Therapieansätze bekannt. Die aktuelle Therapie 
beschränkt sich auf Schmerzhemmung und der Verhinderung von entzündlichen Rezidiven. 
Das Fehlen von effektiven therapeutischen Strategien hängt unter anderem damit 
zusammen, dass die Ätiologie sowie die Pathophysiologie der Pankreatitis noch sehr 
lückenhaft ist. 
In diesem Forschungsprojekt wollten wir die Signalwege untersuchen, welche bei der 
abnormalen Sekretion und somit bei der Auslösung der Krankheit beteiligt sind. Des 
Weiteren untersuchten wir die zwei wesentlichen regenerativen Prozesse, namentlich die 
Progenitorzell-basierte Regeneration und die klonale Proliferation. Durch genetisch 
modifizierte Mäuse und pharmakologische Interventionen wurden die Konzentrationen von 
peripherem Serotonin (5-HT) in vivo moduliert. So konnte gezeigt werden, dass das potente, 
bioaktive Molekül 5-HT die Zymogensekretion reguliert, indem es die Dynamik des Aktin-
Zytoskeletts beeinflusst. Darüber hinaus wurde der Einfluss von 5-HT zur Regulation der pro-
inflammatorischen Mediatoren und der darauffolgenden Entzündungsreaktion untersucht. 
Wir haben auch herausgefunden, dass 5-HT die Azinuszell-Regeneration durch eine 
Reprogrammierung zu Progenitorzellen reguliert. Die Regeneration durch klonale 
Zellproliferation jedoch, bei der differenzierte Azinuszellen proliferieren, wird nicht durch 5-
HT beeinflusst. Insbesondere konnten wir beweisen, dass 5-HT Signale für die Regeneration 
von Azinuszellen nach entzündlicher Zellschädigung notwendig sind. Im Gegensatz dazu 
spielt 5-HT keine Rolle bei der Zellproliferation nach partieller Pankreatektomie oder nach 
mitogener Stimulation.  
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Signifikanz des Projekts: 
Diese Forschungsresultate zeigen, dass 5-HT eine entscheidende Rolle in der 
Ätiopathogenese der Pankreatitis spielt. Insbesondere haben wir gezeigt, dass 5-HT im 
Pankreas die Zymogensekretion fördert, Immunzellen rekrutiert und Geweberegeneration 
begünstigt. Eine weitere Charakterisierung der 5-HT abhängigen Mechanismen auf dem 
molekularen Niveau werden neue Erkenntnisse für das therapeutische Management der 
Pankreatitis hervorbringen, welche möglicherweise die Schäden am Pankreas limitieren und 
gleichzeitig die Geweberegeneration unterstützen. 
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3. Introduction 
Isolated more than 70 years ago, 5‑hydroxytryptamine (5-HT), also known by the name of 
“serotonin”, is a biogenic amine primarily found, in mammals, in the central nervous system 
(CNS), gastrointestinal tract (GI tract) and blood platelets. Despite its relevance in the CNS, 
where this neurotransmitter plays a key role in mood, sleep, sex and appetite regulation, 5-
HT is produced and released by neurons in a relatively small amount. Over 90% of 5‑HT is 
synthesized, stored and released from a subset of enteroendocrine cells, called 
enterochromaffin cells (EC), located in the intestinal mucosa. Other modest but nevertheless 
considerable sources of 5-HT are subtypes of resident granulocytes, called mast cells, 
pancreatic islets, and enteric neurons of the myenteric plexus, both located in the lamina 
propria of human and murine bowels [1-3].  
3.1 5-HT biosynthesis and metabolism 
Biochemically, the synthesis of 5-HT consists in a two-step process. It initiates with the 
conversion of the essential dietary amino acid L-tryptophan to 5-hydroxytryptophan (5-HTP) 
by the cytosolic enzyme L-tryptophan hydroxylase (TPH). Subsequently, the enzyme 
decarboxylase further metabolizes 5-HTP in order to complete the conversion to 5-HT.  
Although both enzymes are necessary for the synthesis of this bioactive molecule, TPH is 
considered the rate-limiting enzyme of the biochemical reaction. This enzyme is mostly 
present in those cells able to produce and store 5-HT. However, many cells contain low 
levels of TPH, which is relatively unstable. Indeed, minor changes in TPH levels or activity 
can dramatically alter 5-HT content and serotonergic functions [4, 5].  
The first gene coding for the TPH enzyme was found on human chromosome 11 and mouse 
chromosome 7 [6]. For a long time this gene was thought to be the only TPH gene in the 
mammalian genome. However, by targeted ablation of this TPH gene (at the present 
identified as TPH1), the existence of a second TPH isoform, TPH2, was discovered. It is 
encoded by an additional gene on human chromosome 12 and mouse chromosome 10. The 
two isoforms share approximatively 71% of similarity, but TPH2 is more selective for 
tryptophan compared to the isoform 1. Furthermore the two enzymes are expressed in 
different tissues: TPH1 is mainly present in gut while TPH2 predominates in the brain stem 
[7, 8]. The existence of these differences ensures a dichotomy of the serotonergic system, 
which has relevant implications for the regulation of 5-HT production in a spatio-temporal 
manner. 
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Figure 1. 5-HTsyntesis and metabolism. Adapted from [9]. 
 
Ninety-nine percent of total body 5-HT is located intracellularly. It is mainly found in 
presynaptic neurons (CNS) and in platelets (periphery), implying a tight regulation of 5-HT 
availability. The concentration of 5-HT in tissues depends not only on the rate of synthesis 
but also on the rate of its metabolism, the latter regulated by the activity of monoamine 
oxidase (MAO). MAO is a mitochondrial enzyme, ubiquitously expressed, that exists in two 
major forms, MAO-A and MAO-B. MAO-A metabolizes the biggest amount of 5-HT and it is 
expressed in most tissues, while MAO-B is found predominantly in blood cells. 5-
hydroxyindoleacetic acid (5HIAA) is the metabolite of 5-HT and it is excreted primarily in the 
urine, within 24 hours in case of exogenous 5-HT administration (Fig.1). Given such a rapid 
clearance, intracellular storage is the mechanism adopted by the organism to prevent 5-HT 
from elimination. 5-HT uptake is mediated by the highly selective serotonin transporter 
(SERT) which is primarily located on presynaptic neurons in the CNS, and on the 
extracellular membrane of platelets. Once taken up, 5-HT is recycled and stored in small 
vesicles (reviewed in [10]). The storage in the vesicles is further mediated  by vesicular 
transmembrane monoamine transporters VMAT1 and VMAT2, both expressed in central and 
peripheral nervous system and in platelet [11] (Fig.2). 
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Mammals employ 5-HT both as a neurotransmitter in central and peripheral nervous 
systems, but also as a local hormone in numerous other tissues, including the GI tract, the 
cardiovascular system and the immune system. The ability of 5-HT to mediate such a 
plethora of roles implies the necessity of a big variety of receptors. Currently, 18 genes are 
annotated to encode 14 distinct mammalian 5-HT receptor subtypes.  
 
 
 
Figure 2. SERT and VMAT-mediated 5-HT uptake in presynaptic terminals. The plasma membrane monoamine transporters 
and vesicular monoamine transporters (VMATs) are members of the soluble carrier (SLC) superfamily and have a major role in 
regulation of the homeostasis and effects of  5-HT. SERT is a plasma membrane transporter belonging to the SLC6 family 
whereas VMATs are members of the SLC18 family. When not sequestered in recycling vesicles, 5-HT is metabolized by the 
mitochondrial enzyme MAO. Adopted from [11]  
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3.2 5-HT receptors 
In the GI tract, 5-HT is released from enterochromaffin cells. It mediates several 
gastrointestinal functions, such as peristalsis, secretion, vasodilation and perception of pain 
or nausea.  In the brain, the neurotransmitter is produced and released by axon terminals in 
response to an action potential and then diffuses across the synapse to activate postsynaptic 
receptors. In both sites, 5-HT signaling is initiated via the activation of a diverse family of 
receptors. 5-HT receptors are a group of G protein-coupled receptors (GPCRs) and ligand-
gated ion channels (LGICs) found ubiquitously in the central and peripheral nervous 
systems, GI tract, vessels and platelets. They are divided into seven 5-HT receptor families 
(5-HT1 to 5-HT7), most of which have multiple subtypes (e.g. 5-HT1A-1F, 5-HT1B, 5-HT2A, 5-
HT2B). The 5-HT receptors are classified according their amino acid homology and their 
coupling to downstream second messenger pathways. The 5-HT1 and 5-HT5 receptor families 
are generally involved in inhibitory pathways reducing the intracellular levels of cyclic 
adenosine monophosphate (cAMP) and regulating Ca2+ channels. The family 1 is also 
responsible for the phosphorylation of mitogen-activated protein kinase (MAPK) and initiates 
growth signaling pathways [12]. On the other hand the families 5-HT2, 5-HT4, 5-HT6, 5-HT7 
activate excitatory pathways increasing intracellular cAMP and PLC activities. Finally, 5-HT3 
mostly regulates negative impulses inducing plasma membrane depolarization and is 
associated with Na+/K+ cation channels. Detailed information regarding 5-HT receptors 
localization and signaling can be found in the table 1. 
Interestingly, structural analyses have recently highlighted the possibility for these receptors 
to achieve a functional diversity by allelic polymorphisms, splice variants, and the formation 
of receptor heterodimers [13, 14]. In addition, 5-HT receptors possess sites susceptible to 
post-translational modification, which can markedly modify their signaling. For instance, 
prolonged stimulation of 5-HT2A receptors leads to their phosphorylation by G-protein-
receptor kinases and/or by protein kinases (PKA and PKC). Phosphorylation of these 
receptors modifies their cell-surface expression and interaction with G-proteins and 
subsequent modulation of second messenger levels, which usually leads to blunted signaling 
[15]. 
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Receptor 
Subtype 
 
Transduction 
Mechanism 
 
Localization 
 
Function 
 
1A 
 
↓AC (Gi/o) Limbic system (hippocampus, lateral 
septum, cortical areas), mesencephalic 
raphe nuclei 
Hyperpolarization, modulation of 
neurotransmitter release, anxiolysis, 
hypothermia, hyperphagia 
 
1B 
 
↓AC (Gi/o) 
Basal ganglia, striatum, amygdala, 
trigeminal ganglion, vascular smooth 
muscle 
Autoreceptor, locomotion, hypophagia, 
hypothermia, modulation of 
neurotransmitter release, 
vasoconstriction 
 
1D 
 
↓AC (Gi/o) 
Basal ganglia, hippocampus, cortex, 
spinal cord, vascular smooth muscle 
Autoreceptor, modulation of 
neurotransmitter release 
 
1E 
 
↓AC (Gi/o) 
Cortex, caudate putamen, claustrum, 
hippocampus, amygdala 
Unknown 
 
1F 
 
↓AC (Gi/o) 
Hippocampus, cortex, dorsal raphe 
nucleus, uterus 
Speculative role in visual and cognitive 
function 
 
 
2A 
 
 
↑ PLC 
Forebrain, caudate nucleus, nucleus 
accumbens, hippocampus, olfactory 
tubercle, vascular smooth muscle, blood 
platelets 
Neuronal depolarization, head twitch, 
hyperthermia, modulation of 
neurotransmitter release smooth muscle 
contraction, platelet activation 
 
2B 
 
↑ PLC 
Brain, stomach fundus (rat), gut, heart, 
kidney, lung 
Contraction of the stomach fundus, 
anxiety 
 
2C 
 
 
↑ PLC 
Choroid plexus, cortex, limbic system, 
basal ganglia 
Hypolocomotion, hypophagia, penile 
erection, hyperthermia, anxiety, ↓ 
noradrenalin and dopamine release 
 
3 
 
Ion channel 
(Na
+
, K
+
, 
Ca
2+)
 
Dorsal vagal complex, hippocampus, 
amygdala, caudate, cerebral cortex, 
heart, intestines 
Anxiety, cognition, pain , 
reward/withdrawal, vomiting reflex, 
vasodilation, intestinal tone and 
secretion 
 
 
4 
 
 
↑ AC (Gs) 
Cerebral cortex, limbic areas, 
hippocampus, colliculus, intestines 
Learning and memory, visual 
perception, anxiety, motor coordination, 
arousal, smooth muscle relaxation, 
modulation of neurotransmitter release 
 
5A 
 
↓ AC (Gi/o) 
Amygdala, hippocampus, caudate 
nucleus, cerebellum, hypothalamus, 
thalamus, substantia nigra, spinal cord 
Modulation of exploratory behavior and 
locomotion 
 
6 
 
↑ AC (Gs) 
Striatum, olfactory tubercles, nucleus 
accumbens, hippocampus, stomach, 
adrenal glands 
Memory and learning, modulation of 
neurotransmitter release 
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↑ AC (Gs) 
Thalamus, hypothalamus, 
hippocampus, cerebral cortex, 
amygdala, GI and vascular smooth 
muscle, heart 
Circadian rhythms, smooth muscle 
relaxation, nociception, hypotension, 
modulation of REM sleep, learning and 
memory, LH release 
 
Table 1: Adapted from Tocris web site 
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3.3 5-HT transporter 
5-HT bioavailability and functions are tightly regulated by a combination of reuptake 
mechanisms, feedback loops, and metabolizing enzymes [16]. The maintenance of a robust 
5-HT signaling largely depends on the precise control of extracellular 5-HT levels. The 5-HT 
uptake transporter SERT is considered the primary molecule responsible for inactivating 5-
HT signaling in the CNS and GI tract. 
SERT belongs to the neurotransmitter/sodium symporter (NSS) family, according to a Na+/Cl-
-dependent mechanism and it mediates the uptake of 5-HT across the membrane of both 
neuronal and non-neuronal cells. SERT has been found in two different isoforms which differ 
not only in length but also in distribution. The peripheral SERT isoform is more abundant and 
shorter compared to the one found in CNS. Its transcription initiates downstream from the 
starting site and a tissue specific regulatory sequence, located within intron 1, determines its 
expression and abundance in the periphery [17]. Generally, SERT function is rapidly inhibited 
in response to acute depletion of intracellular Ca2+, inhibition of calmodulin, Src-kinase, p38 
MAPK and activation of PKC. Otherwise, increased intracellular Ca2+, activation of 
NOS/cGMP and MAPK pathways stimulate SERT activity. Importantly, SERT gene 
expression, activity and clearance are directly or indirectly regulated both by 5-HT receptor 
signaling and 5-HT extracellular availability. In synaptosomes, for instance, it was 
demonstrated that ablation, either genetic or pharmacologic, of the 5-HT1B receptor leads to 
a reduction of SERT gene expression. On the other hand, SERT activity depends on 5-HT2B 
receptor signaling. In the absence of external 5-HT, 5-HT2B receptor ensures SERT 
phosphorylation to basal level and maximal 5-HT uptake. In the presence of 5-HT, the 5-HT2B 
receptor promotes hyper phosphorylation of SERT, impairing the electrochemical gradient 
necessary for the uptake of 5-HT.  
Uptake of 5-HT was considered for long time a scavenger system adopted by the cells either 
to regulate 5-HT signaling, but also to store or metabolize excessive levels of extracellular 5-
HT. However, in 2003 a new biological function was attributed to 5-HT taken up by SERT. 
When internalized, 5-HT is covalently bound to target proteins and thus modifies their 
activity. Accordingly, this post-translational modification was named serotonylation. Multiple 
physiological roles have been identified since its description and  deregulated serotonylation 
was shown in the etiology of bleeding disorders, primary pulmonary hypertension and 
diabetes (reviewed in [18]). 
5-HT uptake mechanism is highly conserved among the species and it takes places in 
several cell types regardless their ability to synthetize 5-HT. During mammals development, 
for example, 5-HT storage is firstly observed in non-neuronal sites such as heart, cranial 
mesenchyme and notochord, and curiously, it takes place in the CNS only during post-natal 
development [19].  
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Regarding the CNS, 5-HT uptake is observed not only in those neurons capable of 5-HT 
synthesis, but also in the non-monoaminergic one. This peculiarity has risen up several 
questions regarding the functional role of 5-HT internalization during CNS development, and 
an exhaustive explanation is still needed. One fascinating hypothesis suggests that during 
cranial development, non-monoaminergic neurons transiently express SERT in order to 
internalize 5-HT which is afterward utilized as a “borrowed neurotransmitter” to modulate 
extra-neuronal signaling. Alternatively, the uptake serves to control the extracellular level of 
5-HT avoiding excessive receptor stimulation and guaranteeing the correct 5-HT gradient 
during brain development [20].  
The example of 5-HT trafficking in the periphery highly supports each of the mentioned 
hypothesis. Platelets, for instance, capture 5-HT from the bloodstream and store it in dense-
core vesicles. Also in this cell type, 5-HT is not produced by platelets but it is rather used as 
a borrowed transmitter released in case of tissue damage or allergic reactions which imply 
platelet activation. In other cases, such as intestinal crypt cells or endothelial cells, the 
expression of SERT and the function of heterologous 5-HT uptake serve as a clearance 
pathway aiming to inactivate the 5-HT produced and released by neighboring cells [21, 22] 
(Fig.3). A better understanding of the signaling pathways influencing SERT expression and 
functions will shed light on the myriad of pathways through which this neurotransmitter 
regulates central and peripheral activities. 
 
 
 
Figure 3. Circulation of 5-HT between cells that produce 5-HT and those that capture it: in the blood, circulating 5-HT derives 
essentially from the enterochromaffin cells. Plasma 5-HT is captured and concentrated by platelets, which release it on 
stimulation. In the gut, enterochromaffin cells release 5-HT that is captured by the crypt cells, which metabolize the amine. In the 
developing brain, 5-HT is produced by raphe neurons and is captured by thalamic axons, which store it in synaptic vesicles. 
Adapted from [23]. 
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3.4 5-HT signaling in the brain 
In the adult CNS, 5-HT is produced by a moderate-size cluster of neurons originating in the 
raphe nuclei located in the midline of the brainstem. Raphe nuclei consist in a heterogeneous 
population of neurons with distinct morphologies, projections and neurochemical 
characteristics, among which the serotonergic neurons are the most representative. These 
neurons are functionally diverse according to their localization: descending medullary raphe 
projections influence spinal and brainstem mechanisms and are mostly involved in the 
central modulation of pathologic pain syndromes occurring in the bowel [24]. By contrast, the 
ascending raphe projections are implicated in the regulation of mood, sleep, sex, appetite, or 
most generally, all human behavior [25]. Human behaviors result, indeed, by the combined 
signaling of several 5-HT receptors, expressed in multiple brain regions, which 
simultaneously modulate several processes. For example, anxiety-like behaviors are 
regulated primarily by 5-HT1A and 5-HT2C receptors. However, the 5-HT2C receptor, beside 
anxiety, regulates also reward, appetite, locomotion, and energy balance. For this reason, 
pharmacological treatment targeting 5-HT2C receptor may affect multiple and apparently 
unrelated behavioral processes (reviewed in [26]).  
An intriguing and at the same time puzzling issue regards the role of 5-HT in brain 
development. Studies on murine models reported that during this stage, receptors, 
transporter and degrading enzymes of 5-HT appear much earlier than the serotonergic 
innervation [27]. A new rising hypothesis postulates that during early embryogenesis, a 
tryptophan metabolic pathway in the maternal placenta constitutes the extra-embryonic 
source of 5-HT, which influences not only the fetal brain development (via specific receptor 
signaling) but also its long-term functions [28]. A typical example is the 5-HT1A receptor which 
is expressed in the raphe nuclei and in the hippocampus during early developmental stage 
and it is stimulated by maternal 5-HT. After the gestation, this receptor is transiently 
expressed in hippocampal dendritic spines and is responsible for their post-natal elongation 
[29]. Finally, in adulthood, its signaling is associated with anxiety-like behavior [26, 30].  
Differently, the 5-HT2A receptor does not actively take part to embryonic brain development 
since its early ablation is not associated to any developmental CNS abnormalities. Its 
activation is rather crucial during the post-natal phase for the maturation of phrenic motor 
neurons, which are indispensable for breathing and control the functions of the diaphragm. 
Nevertheless, the 5-HT2A receptor is the most expressed subtype in nearly all adult brain 
regions and its over-expression on post-synaptic neurons is associated to depressive 
behavior [31].The examples reported above emphasize the concept that 5-HT receptor 
expression and activities cannot be limited to a specific brain region or developmental stage 
but rather they have to be considered highly dynamic and represent a particularly complex 
signaling system.  
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3.5 5-HT signaling in the gastrointestinal tract  
Although the enteric nervous system (ENS) has been defined the “second brain” due to its 
functional autonomy, in terms of anatomy it is intrinsically connected to the CNS via motor 
and sensory fibers (vagus nerves) of the parasympathetic nervous systems.  
Since its discovery, 5‑HT was proposed to be one of the key neurotransmitter bridging the 
two systems during gut activity. The exact mechanisms through which 5-HT connects these 
two compartments have yet to be definitely established but scientists tend to favor a neuro-
endocrine cross-talk in which enterochromaffin cells act as sensory transducers which 
respond to increased intraluminal pressure (due to food intake) by secreting 5-HT that locally 
activates serotonergic sub-mucosal neurons. This hypothesis, formulated already in the early 
1980 when 5-HT was found to induce a propulsive motor function in mammalian intestine 
[32], was later on corroborated by several analyses showing that ascending contractile and 
descending relaxant limbs of peristaltic reflex were depending respectively on 5-HT3 and 5-
HT4 receptors located on enteric afferent neurons [16, 33-36]. In the last decades, however, 
follow up studies have clarified that gut-derived 5‑HT is not necessary to initiate this reflex. In 
fact, general Tph1 knock out mice, although deficient in gut-derived 5-HT, do not show any 
dramatic alteration in intestinal motility suggesting that enterochromaffin-derived 5-HT does 
not evoke peristaltic reflexes, but only modulate them [36, 37]. On the other hand, lack of 
TPH2, whose expression in gut is minimal and occurs exclusively in enteric neurons, results 
in slower gastrointestinal transit time, intestinal propulsion and colonic motility and faster 
gastric emptying, suggesting that serotonergic neurons are more critical than 
enterochromaffin cells in regulating gut motility. Of note, lack of TPH2 in gut is primarily 
associated to a disrupted myenteric plexus formation, which normally takes place during 
embryogenesis. For this reason dysmotility found in TPH2 knockout mouse may reflect either 
an alteration in serotonergic neurotransmission and/or changes in the 5-HT “microsystem” 
(release/uptake, receptor signaling) due to loss of neurons [37].  
Not only mechanical stimuli, such as augmented luminal pressure, but also chemical stimuli 
were found to specifically modulate 5-HT release and signaling in the ENS. In presence of 
glucose, enterochromaffin cells release 5-HT that excites the receptors located on afferent 
nerve terminals to evoke gastric motility and delay gastric empting [38]. In case of lipid 
intake, 5-HT receptors and cholecystokinin (CCK) receptors are activated in order to signal 
back the sense of satiety [39].  
5-HT has also the ability to coordinate, via neuronal and not neuronal pathways, secretory 
processes that culminate into the release of electrolytes, mucus, fluids and enzymes by 
intestinal epithelial cells [40] and pancreatic cells [41, 42]. 
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3.6 5-HT-mediated pancreatic secretion 
Situated in the retroperitoneal cavity, the pancreas is an organ which acts both as an 
endocrine gland secreting hormones, and as an exocrine gland secreting digestive enzymes. 
The endocrine part, which represents approximatively 5% of the organ, is organized in 
functional units called islets of Langerhans where five hormone-secreting cell types, called β, 
α, ,  and - cells, are clustered. A dense network of capillaries crisscrosses the islets of 
Langerhans, and constitutes a physical connection between the endocrine cells and the 
surrounding blood vessels. This proximity in terms of space ensures a prompt release of 
hormones, such as insulin, glucagon, and somatostatin, in response to blood glucose level 
variations. Insulin secretion, in particular, was recently found to be regulated by a non-
neuronal 5-HT signaling. 5-HT is synthesized within β-cells by TPH1 enzyme [3], is stored 
together with insulin in β-granules and it actively takes part to insulin secretion via 
autocrine/paracrine pathways. Paulmann and colleagues have demonstrated that lack of 
peripheral 5-HT in Tph1-/- mice leads to a significant reduction of β-cells insulin secretion, 
increased insulin resistance and appearance of a diabetic type II phenotype. 
Pharmacological administration of 5-HT in these mice rescued insulin secretion and reverted 
the resistance. In his study, Paulmann elegantly demonstrated that, under physiological 
conditions, intracellular rather than extracellular 5-HT is crucial for hormonal secretion. After 
being taken up by SERT, localized on β-cells membranes, 5-HT binds and thus activates 
small GTPases, namely Rab3a and Rab27a, which actively promotes the β-granules 
secretory process [43].  
Additional investigations performed on pregnant animal models displaying temporary 
gestational diabetes, further emphasized the fundamental role of 5-HT in β-cells secretion. 
Upon lactogenic signaling, Tph1 expression and activity increase dramatically, islets increase 
their cell mass and a temporary insulin resistance arises [44-46]. Different 5-HT receptor 
subtypes were found to directly regulate β-cell proliferation and glucose-induced insulin 
secretion during the gestational time [44, 47]. It is worth to mention that in this particular 
condition, granule exocytosis resulted from an extracellular 5-HT signaling via cell-surface 
receptor and no involvement of intracellular 5-HT was detected [47]. Collectively, the above 
mentioned studies on β-cell secretion highlight that the 5-HT microsystem is so complex that 
one cell function, such as granule exocytosis, depends on multiple pathways. 
The exocrine or “digestive” part of the organ is composed of ductal and acinar cells (Fig.4).  
In the adult pancreas, ductal cells represent the minor cell type and, besides forming a 
network that delivers enzymes from acini into the digestive tract, they produce bicarbonate 
that neutralizes stomach acidity and balance the pH of pancreatic juice [48]. Notably, a non-
neuronal 5-HT receptor-mediated signaling was proposed to negatively control the 
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bicarbonate secretion, data recently supported by the evidence that lack of peripheral 5-HT 
results in increased ductal bicarbonate secretion [49]. 
Acinar cells are highly polarized units that produce, store and release digestive enzymes 
necessary for proper food digestion and absorption. These enzymes, namely amylase, lipase 
and proteases, are the major constituent of the so called pancreatic juice. These enzymes 
are secreted through the apical membrane of acinar cells into small branched intercalated 
ducts that drain this fluid through a dense network of tubular structures eventually joining the 
main pancreatic duct (Fig.4). Pancreatic digestive enzymes are produced in the endoplasmic 
reticulum as precursor molecules (zymogens) and stored into membrane-enclosed 
compartments called zymogen granules. Specifically, most zymogens contain an inhibitory 
domain that keeps them inactive until a cascade of enzymatic cleavage steps removes them. 
Trypsinogen, the precursor form of trypsin, is committed to initiate the proteolytic cascade 
and thus converts the zymogens not yet activated. Physiologically, the activation of 
trypsinogen into its active form is carried out by the brush-border enzyme enterokinase 
(belonging to enteropeptidase family) in the small intestine. 
As discussed above, most of the pancreatic functions are controlled both by neuronal and 
non-neuronal pathways. In line with this concept, secretion of digestive enzymes is the result 
of the stimulation of both pathways. Hormones such as secretin, CCK, gastrin releasing 
peptide (GRP), substance P, vasoactive intestinal peptide (VIP) and acetylcholine bind their 
corresponding acinar receptors and, through interaction with G-proteins, trigger the process 
of receptor-mediated secretion. At the same time, enzymatic secretion is also induced by the 
synergistic stimulation of CCK and 5-HT receptors localized on vagal afferent fibers [41, 50].  
More than 30 years ago, it was proposed that pancreatic rat acinar cells could produce and 
release a little amount of 5-HT and, similarly to what happens in β-cells, 5-HT was co-
localized in mature amylase- containing zymogen granules [51]. However, since this 
preliminary observation, the exact role of 5-HT in acinar cells zymogen granules has not 
been clarified. 
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Figure 4. The cellular components of the pancreas. The pancreas consists of endocrine cells organized in clusters called Islets 
of Langerhans, which contain multiple endocrine cell types including the β cells that secrete insulin.  The exocrine pancreas is 
composed of acinar and ductal cells. Pancreatic acinar cells are organized in small structures called acini that surround central 
lumen open to the duct system. Pancreatic acinar cells produce, store and secrete enzymes necessary for food digestion and 
absorption. Enzyme secretion occurs through the apical membrane of the acinar cell into small intercalated ducts that are 
directly connected to increasingly larger intralobular ducts that join the main pancreatic duct. Adopted from [52] 
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3.7 Aberrant pancreatic secretion and pancreatitis  
Under physiological conditions, pancreatic acinar cells are constantly subjected to high levels 
of stress due to their elevated protein synthesis, packaging, secretion and also because 
unexpected premature activation of newly synthesized zymogens may damage intracellular 
components requiring a prompt recovery. In this case, repairing systems, such as the 
presence of intracellular trypsin inhibitors or proteases degrading the activated zymogens, 
normally prevent cellular damage. Whenever the mentioned protective mechanisms are 
disrupted, zymogens are activated intracellularly and acinar cell auto-digestion initiates. This 
type of injury evokes an inflammatory response. 
Clinically defined as “pancreatitis”, pancreatic inflammation is classified either as acute or 
chronic according to the evoked inflammatory response. Acute pancreatitis is associated 
either to a mild and localized inflammation, which generally resolves in a relatively short time, 
or to a more severe and systemic one, which leads to multiple organ dysfunction and death. 
On the other hand, chronic damage is mostly characterized by recurrent phases of acinar cell 
destruction and replacement, either with fibrotic or fat tissue, which culminates in exocrine 
insufficiency.  
A number of risk factors are associated with the onset of pancreatitis, namely bile duct 
obstruction by gallstones, alcohol abuse, smoke, high fat diet, infection or trauma; however a 
clear pathogenic mechanism is not yet established. High levels of intracellular activated 
trypsin are known to exacerbate acute pancreatitis causing acinar cell apoptosis [53] or 
autophagy [54]. However, more recent and controversial evidence suggest that the 
intracellular trypsin activation is sufficient to initiate pancreatitis but it does not determine the 
severity of the local inflammation [55, 56]. In fact, recent studies report, that extracellular but 
not intracellular activated trypsin, is able to stimulate the pro-inflammatory gradient [55, 57, 
58], suggesting that trypsin not only has to be aberrantly activated but it must be secreted 
ectopically in the interstitial space in order to dramatically contribute to tissue injury.  
The precise molecular mechanisms regulating the ectopic interstitial secretion during 
pancreatitis remain largely unclear. It was proposed to be largely dependent on cytoskeletal 
remodeling in acinar cells. Pancreatic acinar cells, like other secretory cells, have a dense 
web of actin filaments immediately beneath their plasma membrane, better known as 
terminal web. Under resting conditions, this structural component prevents secretory 
granules from reaching their exocytic destination acting as a physical barrier. During granule 
exocytosis, this web is temporarily perturbed allowing granules containing enzymes to dock 
and fuse with the apical plasma membrane and finally release their content into ductal 
lumens. Dysregulation of this mechanism is currently believed to be a contributing cause of 
clinical acute pancreatitis. Experiments performed on isolated rodent acinar cells revealed 
that stimulation of enzymatic secretion with supramaximal doses of CCK, or its synthetic 
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analogue cerulein, induces a massive disruption of terminal actin web with the consequent 
block of apical secretion and a redirection of exocytosis toward the baso-lateral cell 
membrane [59]. It was also clarified that upon CCK stimulation both actin remodeling and 
granule exocytosis were mediated by small GTPases such as Rho, Rac and Rab [60, 61]. 
Although ectopic secretion is certainly crucial for initiation of pancreatitis, it is worth to 
mention that several other impaired cellular processes may independently initiate tissue 
damage. Endoplasmic reticulum stress due to excessive protein synthesis, ROS production 
or impaired protein folding/packaging, stimulates the secretion of pro-inflammatory cytokines, 
which locally recruit and activate inflammatory cells. Shortly after the initial insult, acinar cell 
secrete pro-inflammatory factors like TNF-α, IL-6, IL-1β, and MCP-1, recruiting firstly 
neutrophils and then macrophages which exacerbate the tissue injury. In concomitance with 
this inflammatory cell influx, acinar cells initiate a proliferative process. Surrounded by 
inflammatory cells, and possibly influenced by their secretome, a portion of acinar cells 
undergo a trans-differentiation program. At first, a general loss of enzymatic content is 
observed, accompanied by a robust down regulation of genes responsible for zymogen 
production. Subsequently, a portion of acinar cells acquire a new identity losing their polarity 
in favor of a more cuboid shape, shrinking and remodeling their cytoskeletal architecture and 
becoming highly proliferative cells organized into duct-like structures. Furthermore, these 
structures better identified as acinar-to-ductal metaplasia (ADM), transiently express not only 
genes typical of pancreatic embryogenesis, namely Hnf6, Pdx1, Notch1 and Hes1, but also 
those  normally restricted to adult duct cells, such as cytokeratin 19 (CK19) and Sox9 [62-
64]. In the absence of further inflammatory relapses, re-differentiation into functional acinar 
cells occurs rapidly within one week after cessation of the insult. 
Histological analysis on human specimens strongly suggests that the above mentioned 
regenerative process is likely to happen also during human pancreatitis. Damaged human 
pancreata, surgically resected upon pancreatitis, display increased proliferation of intact acini 
and histological changes consistent with ongoing regeneration, including ADM formation.  
Of note, concomitant acinar trans-differentiation and proliferation are easily reproducible in 
rodents using the model of cerulein-induced pancreatitis and their extent can be prolonged or 
intensified simply by modulating the drug treatment [65]. Taken together, these observations 
suggest that the process of trans-differentiation represents a protective mechanism adopted 
by acinar cells in response to aberrantly secreted enzymes. 
The entire proposed mechanism is summarized in the Fig.5 reported below.  
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Figure 5.  Schematic representation of pancreatitis progression.  Please note as during acinar cell trans-differentiation phase, 
nuclei express markers of pancreatic embryogenesis and markers restricted to adult ductal cells. During the regenerative phase, 
both intact acini and trans-differentiating foci become highly proliferative. 
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4. Aim of the project   
Early in the course of pancreatitis, premature activation and ectopic interstitial secretion of 
pancreatic digestive enzymes lead to acinar cell injury and necrosis characteristic of this 
disease.  This early event culminates first into a severe inflammation and then, in the 
absence of additional insults, into tissue recovery.  
Although several information were gained in the last decades regarding the subsequent 
phases of pancreatitis, the molecular mechanisms regulating aberrant acinar cell secretion 
and tissue recovery following tissue damage remain largely unclear.  
In the search of the molecular mechanisms regulating both pancreatic acinar cell ectopic 
secretion and regeneration, we focused our attention on 5-HT, a potent bioactive molecule 
recently found to modulate cell secretion but also well known for its mitogenic properties. 
 
Hence, we hypothesize that 5-HT may play a decisive role in two fundamental phases 
of pancreatitis, namely acinar cell secretion and acinar cell regeneration. 
 
In particularly we aim to: 
1) Investigate whether 5-HT regulates zymogen secretion in pathological conditions. 
To address this question we analyzed acinar cell secretion in a genetically modified mouse 
model lacking tryptophan hydroxylase 1 (Tph1−/−), the rate limiting enzyme for the synthesis 
of peripheral 5-HT. Pathological consequences were evaluated in adult animals (8-10 weeks 
of age) during the course of pancreatitis caused by multiple intraperitoneal administration of 
cerulein. In addition, AR42J cell, a rat acinar cell line with remarkable secretory 
characteristics, and freshly isolated acinar cells were utilized to investigate the role of 
intracellular 5-HT on enzymatic dynamic.  
 
2) Analyze whether 5-HT acts as a mitogenic factor for pancreatic acinar cells, thereby 
promoting pancreatic tissue regeneration. To answer this question, we compared three 
types of regenerative stimuli, namely cerulein-induced pancreatitis, partial pancreatectomy 
and thyroid hormone supplementation, inTph1−/− mice and in wild-type mice supplemented 
with 5-HT precursor. In particular, we evaluated whether circulating 5-HT was necessary for 
acinar cell proliferation in a context of inflammation-mediated damage and tissue loss 
following surgery. Furthermore, we also evaluated whether 5-HT availability could influence 
the proliferation of healthy and already proliferating acinar cell independently stimulated with 
a second mitogenic factor. 
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Abstract  
Objective: Serotonin (5-hydroxytryptamine, 5-HT) 
is a potent bioactive molecule involved in a variety 
of physiological processes. In this study, we 
analyzed whether 5-HT regulates zymogen 
secretion in pancreatic acinar cells and the 
development of pancreatic inflammation, a 
potentially lethal disease whose pathophysiology is 
not completely understood.  
Methods: 5-HT regulation of zymogen secretion 
was analyzed in pancreatic acini isolated from wild-
type or tryptophan hydoxylase-1 knock-out (TPH1
-/-
) mice, which lack peripheral 5-HT, and in 
amylase-secreting pancreatic cell lines. 
Pancreatitis was induced by cerulein stimulation 
and biochemical and immunohistochemical 
methods were used to evaluate disease 
progression over two weeks.  
Results: Absence and reduced intracellular levels 
of 5-HT inhibited the secretion of zymogen 
granules both ex vivo and in vitro and altered 
cytoskeleton dynamics. In addition, absence of 5-
HT resulted in attenuated pro-inflammatory 
response after induction of pancreatitis. TPH1
-/-
 
mice showed limited zymogen release, reduced 
expression of the pro-inflammatory chemokine 
MCP-1 and minimal leukocyte infiltration compared 
with wild-type animals. Restoration of 5-HT levels 
in TPH1
-/-
 mice recovered the blunted inflammatory 
processes observed during acute pancreatitis. 
However, cellular damage, inflammatory and 
fibrotic processes accelerated in TPH1
-/-
 mice 
during disease progression.  
Conclusions: Our results identify a 5-HT-mediated 
regulation of zymogen secretion in pancreatic 
acinar cells. In addition, they demonstrate that 5-
HT is required for the onset but not for the 
progression of pancreatic inflammation. These 
findings provide novel insights not only into the 
normal physiology of pancreatic acinar cells, but 
also into the pathophysiology of pancreatitis, with 
potential therapeutic implications. 
 
 
 
 
 
 
 
 
 
 
What is already known about this subject? 
 Impaired zymogen secretion is a central event 
in the pathophysiology of pancreatitis. 
 Alterations in actin cytoskeleton are involved in 
the secretory defect observed in acinar cells.  
 Serotonin modulation of zymogen secretion 
has not yet been proposed. 
 
What are the new findings? 
 We provide evidence that serotonin regulates 
zymogen secretion and actin dynamics in 
pancreatic acinar cells. 
 TPH1
-/-
 mice defective in peripheral serotonin 
showed reduced zymogen secretion 
accompanied by limited inflammatory response 
following induction of acute pancreatitis. 
 Lack of serotonin increased pancreatic cellular 
damage, inflammation and fibrosis during 
pancreatitis progression toward a chronic 
stage. 
 
How it might impact on clinical practice in the 
foreseeable future? 
 Comprehensive characterization of the early 
events during development of pancreatitis is 
critical to understand the pathophysiology of 
the diseases and to supply a strong foundation 
for the discovery of new treatments. 
 Our findings reveal the pivotal role 5-HT plays 
in the secretory processes in pancreatic acinar 
cells. Absence of this molecule influences both 
the onset and the progression of cerulein-
induced pancreatitis. 
 Collectively, our findings provide new insights 
into pancreatic pathophysiology and highlight 
the potential and limitations of therapeutic 
strategies based on 5-HT-mediated pathways 
during pathological inflammatory events. 
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Introduction 
Acute pancreatitis (AP) is an inflammatory disorder 
of the pancreas, which in its severe form is 
associated with a mortality rate of 15-25%. [1] The 
etiologic factors involved in the initiation and 
aggravation of AP are still poorly understood, and 
the treatment of the disease is limited to supportive 
therapy.[2] Thus, efforts to understand the 
pathophysiology of this disorder and to develop 
clinical strategies to attenuate the disease 
progression are imperative. 
Results from human studies and murine 
experimental models indicate that activation of 
zymogen proteases inside acinar cells, a central 
and early event in pancreatitis, is not sufficient to 
induce acinar cell injury but must be coupled with a 
reduction and redirection of zymogen secretion 
from the apical to the basolateral membrane of 
acinar cells, thus highlighting the importance of 
secretion in disease initiation (reviewed in [3, 4]). 
While the precise molecular mechanisms 
regulating this aberrant secretion remain largely 
unclear, ex vivo studies on isolated pancreatic 
acini indicated that disturbance of apical actin 
cytoskeleton dynamics mediated by cellular small 
GTPases are implicated in the process.[5, 6] To 
further investigate the mechanisms regulating 
zymogen secretion both in physiological and 
pathological situations, we analyzed whether 
serotonin (5-hydroxytryptamine, 5-HT) regulates 
the secretory processes in pancreatic acinar cells. 
The generation of tryptophan hydoxylase-1 knock-
out (TPH1
-/-
) mice in which 5-HT is absent in the 
peripheral circulation, but remains unaffected in the 
central nervous system, [7] has been a pivotal 
instrument to reveal the numerous roles of 5-HT 
outside the nervous system. These extend from 
modulation of organ regeneration, as recently 
demonstrated by our group in liver following 
hepatectomy,[8] to regulation of inflammatory cell 
activity.[9, 10, 11, 12, 13] Importantly, 5-HT has 
also been shown to regulate secretion in two cell 
types, namely platelets,[14] and pancreatic β 
cells.[15] In both cell systems, 5-HT exerted its 
regulatory action by modifying and thus activating 
intracellular proteins, including small GTPases, via 
a transglutaminase-mediated process known as 
serotonylation. In addition, recent evidence 
indicates that serotonylation is found on 
cytoskeletal proteins including actin and regulates 
contractility in vascular smooth muscle,[16, 17] and 
membrane architecture in intestinal epithelial 
cells.[18] This suggests that 5-HT is also likely to 
regulate structural processes. 
The observation that 5-HT modulates the activity of 
small GTPases and actin cytoskeleton, and that 
both these elements are involved in the secretory 
process of pancreatic acinar cells, lead us to 
hypothesize that 5-HT may be a key factor in 
regulating zymogen secretion both in physiological 
and pathological situations. To address this 
question we analyzed acinar cell secretion and 
pathophysiological consequences in the pancreas 
using 5-HT deficient TPH1
-/-
mice. 
Materials and methods 
Animal experiments 
All animal experiments were in accordance with 
swiss federal animal regulations and approved by 
the cantonal veterinary office of Zurich. 
Pancreatitis was induced in adult (8-10 weeks of 
age) wild-type (WT) C57BL/6 (Harlan Laboratories, 
Horst, The Nederlands) and TPH1
-/-
 mice,[7] on a 
C57BL/6 background (own breeding) via intra 
peritoneal (i.p.) administration of six hourly 
injections of 50 µg/kg cerulein over a two week 
period, as described.[19] Reloading with the 
serotonin precursor 5-HTP was performed with 20 
mg/kg 5-HTP by two sub cutaneous (s.c.) 
injections per day, 12 hours apart. The treatment 
was performed on alternate days, commencing 
one day before the cerulein treatment; control 
animals received 0.9% NaCl injections. 
Isolation of pancreatic acini  
Pancreatic acini from WT and TPH1
-/-
 mice were 
prepared by enzymatic digestion with collagenase 
followed by mechanical shearing, as described.[20] 
Acini were pacified in Kaighn’s modified Ham’s F-
12 medium containing penicillin (50 U/mL) and 
streptomycin (50 µg/mL) supplemented with 10% 
WT or TPH1
-/- 
serum at 37°C in a 5% CO2 
atmosphere for 45 min. Acini were then stimulated 
in medium containing 10% mouse WT or TPH1
-/-
 
serum with cerulein at the concentrations indicated 
in the figure legends. After 15 and 60 min 
incubation at 37°C, the samples were fixed and 
stained for amylase, as described below, or 
assessed for amylase secretion, respectively, 
using the Cobas c111 analyzer (Roche). Amylase 
release was expressed as a percentage of 
secreted amylase normalized by protein content. 
In vitro amylase secretion assay 
105 rat pancreatic AR42J cells (ATCC, CRL-1492) 
cells were seeded in a 12 well plate, incubated 
with 50 nM dexamethasone for 24 hours to induce 
differentiation, then treated with the compounds at 
the concentrations and time indicated in the figure 
legend and stimulated with 10 nM cerulein. After 
60 min, the acinar suspension was centrifuged and 
the supernatant and lysed cell pellets assayed for 
amylase activity. 
Histology and immunohistochemistry  
Detailed protocols and primary antibodies used in 
this study are listed in Supplementary Materials 
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and Methods. Quantification of TUNEL, HMGB1, 
Ki-67, PU.1, F4/80, CD3, HO-1-positive cells was 
performed in at least ten randomly selected high-
power fields (×100) per slide. Non-acinar tissue 
areas (islets, vessels, fibrotic tissue) were 
excluded from the analysis. 
Transcript analysis 
Total RNA was extracted from pancreata as 
previously described.[21] Transcript levels were 
normalized using 18S RNA as a reference and 
expressed as fold induction relative to the value of 
untreated control animals, set as one, as 
described.[22] Taqman probes (Applied 
Biosystems) used in this study are listed in 
Supplementary Materials and Methods. 
Results 
Reduced availability of 5-HT inhibits zymogen 
granule secretion  
To test whether 5-HT regulates secretory 
processes in pancreatic acinar cells, we isolated 
acini from wild type (WT) and TPH1
-/-
 animals. 
Serum (Fig. S1) and pancreatic levels of 5-HT in 
these animals are below 10% of the WT mice, 
while pancreas mass and morphology are 
indistinguishable between the two strains.[15] 
TPH1
-/-
 pancreatic acini accumulated amylase 
positive vesicles (Fig. 1A) and showed increased 
amylase content (Fig. 1B) compared with WT acini. 
In addition, while basal amylase secretion was 
comparable in the two strains, TPH1
-/-
 acini 
secreted less amylase when treated with the 
secretagogue cerulein (Fig. 1C), suggesting that 5-
HT regulates zymogen secretion in pancreatic 
acinar cells. To further dissect the role of 5-HT in 
this process, we treated dexamethasone-
differentiated AR42J cells, the most commonly 
used cell line that maintains the secretion 
characteristics of normal pancreatic acinar 
cells,[23] with modulators of 5-HT-dependent 
pathways. Treatment with the 5-HT reuptake 
transporter (SERT) inhibitor fluoxetine, which 
lowers the intracellular 5-HT content, reduced both 
basal and cerulein-stimulated amylase secretion 
(Fig. 1D), without decreasing the metabolic activity 
of the cells (Fig. S2). Confocal analysis showed 
that, as observed in acini from TPH1
-/-
 mice, 
fluoxetine treatment induced intracellular 
accumulation of amylase positive vesicles (Fig. 
1E), indicating that the observed decrease in 
amylase secretion is due to impaired trafficking 
and not to decreased enzyme synthesis. In 
addition, treatment with cysteamine, a 
transglutaminase inhibitor which reduces the 
process of protein serotonylation and 
serotonylation–dependent secretion, [15] 
moderately reduced amylase secretion in AR42J 
cells (Fig. 1D). Conversely, amylase secretion did 
not change following incubation with the 5-HT2 
-methyl-5-HT, but decreased 
following treatment with GR127935 and LY266097, 
specific antagonists of the 5-HT receptors 5-HT1B 
and 5-HT2B  expressed in  mouse pancreata (data 
not shown and [24]) (Fig. 1D). However, both 
compounds also decreased the metabolic activity 
of the cells (data not shown), thus it is possible that 
the reduced secretion is secondary to impaired 
cellular viability. 
Reduced availability of 5-HT modulates actin 
cytoskeleton dynamics 
In vivo administration of high doses of cerulein 
perturbs the apical localization of zymogen 
granules and redirects their exocytosis to the 
basolateral membranes of pancreatic acinar cells. 
Importantly, this aberrant secretion is accompanied 
by reorganization of actin cytoskeleton and loss of 
cell polarity.[25] To analyze whether 5-HT 
modulates granule dynamics in vivo, we treated 
WT and TPH1
-/-
 mice with high doses of cerulein. 
Zymogen granule content increased in both strains 
24h after treatment, indicating that TPH1
-/-
 acinar 
cells are responsive to the administered cerulein. 
As expected, in WT mice the granule polarization 
was perturbed, as demonstrated by the 
appearance of granules surrounding the nuclei and 
in close contact with the basolateral membranes 
(Fig. 2A). However, in TPH1
-/-
 animals the granules 
maintained an apical localization and their re-
localization to the basolateral membrane was 
rarely observed. As zymogen secretion intersects 
with the apical actin cytoskeleton, we tested 
whether the secretory defect observed in the 
absence of 5-HT was accompanied by cytoskeletal 
alterations. Staining for Rac1, a member of the 
Rho family involved in actin reorganization and 
amylase secretion in pancreatic acinar cells, [5, 6] 
revealed homogeneous cytosolic staining in 
pancreatic cryosections of untreated mice but a 
more pronounced re-localization to acinar 
periphery in TPH1
-/-
 mice 8h after starting the 
cerulein treatment (Fig. 2B). In addition, phalloidin 
staining in untreated WT mice showed actin 
labeling predominantly in centroacinar regions and 
re-localization to basolateral membranes 8h after 
treatment, as observed in treated isolated acini.[5, 
26] (Fig. 2C, arrows). Conversely, in untreated 
TPH1
-/-
 actin labeling was clearly detected 
surrounding individual acinar cells, becoming more 
diffuse and cytosolic during cerulein stimulation. To 
further test the involvement of 5-HT in actin 
cytoskeleton dynamics we monitored the formation 
of cerulein-induced protrusions in acinar cells, a 
process dependent on actin re-organization.[5, 27] 
While 15 min cerulein treatment induced the typical 
protrusions in AR42J cells, fluoxetine pre-treatment 
prevented protrusion formation (Fig. 2D). 
Furthermore, fluoxetine also inhibited the 
protrusions induced by the F-actin stabilizing agent 
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jasplakinolide (Fig. 2D), indicating that the 5-HT-
mediated effect on cytoskeleton is not dependent 
on cerulein stimulation. Collectively, these results 
suggest that 5-HT is involved in actin cytoskeleton 
dynamics. 
Reduced availability of 5-HT limits zymogen 
release and leukocyte infiltration in cerulein-
induced acute pancreatitis 
Cerulein-induced aberrant acinar secretion, which 
is currently the best model for clinical interstitial 
AP,[28] releases zymogens into the interstitial 
space and eventually in the blood circulation. Thus 
we evaluated whether the reduced acinar cell 
secretion observed in absence of 5-HT ex vivo 
resulted in reduced zymogen release in circulation 
in vivo. Serum amylase (Fig. 3A) and lipase (data 
not shown) levels were lower in TPH1
-/-
 than in WT 
mice at 8h and 24h after AP induction, suggesting 
that absence of 5-HT did indeed reduce cerulein-
induced aberrant secretion.  To further evaluate 
whether the absence of 5-HT limited leukocyte 
infiltration, a critical step in the pathophysiology of 
the disease, we analyzed pancreata 24h after AP 
induction when the inflammatory response is 
robust in the organ. Immunostaining analyses with 
the pan-leukocyte marker coronin-1 showed that 
fewer leukocytes were recruited to the pancreas 
(Fig. 3B) and spleen (Fig. S3) and entered the cell 
cycle (Fig. 3C) in TPH1
-/-
 than WT mice. In parallel 
with the limited leukocyte infiltration, pancreatic 
acinar cells were less sensitive to induction of 
apoptosis in TPH1
-/-
 than WT animals while acinar 
necrosis was comparable in both strains (data not 
shown), suggesting that 5-HT does not promote 
necrosis under these experimental conditions. In 
addition, oxidative stress, measured by lipid 
peroxidation levels, was not detectable (Fig. S4).  
In addition, we assessed whether leukocyte 
subpopulations were differentially recruited in the 
absence of 5-HT. Immunolabeling for PU.1, 
expressed in myeloid cells including neutrophils 
and macrophages, showed fewer positive cells in 
TPH1
-/-
 pancreata (Fig. 3D). Both staining (Fig. 3D) 
and mRNA quantification (data not shown) of 
F4/80 revealed that the amount of mature tissue 
macrophages did not differ significantly in the two 
mouse strains while neutrophil MPO levels were 
lower in TPH1
-/-
 pancreata compared with WT mice 
(Fig. 3E), suggesting that 5-HT regulates this cell 
population in our AP model. Furthermore, staining 
for T-lymphocytes (CD3) and macrophage-
dependent hemeoxigenase-1 (HO-1) showed a low 
level of infiltration comparable in the two mouse 
strains (Fig. 3D). This indicates not only that T-
lymphocytes constitute a minor proportion of 
infiltrating cells but also that the induction of HO-1 
in macrophages as a defense mechanism against 
oxidative stress is not pronounced at this time 
point. 
Moreover, analysis of cytokine/chemokine 
expression showed that transcript levels of the 
potent chemokine MCP-1 strongly increased in WT 
animals after AP induction while the increase was 
modest in TPH1
-/-
 mice, thus correlating with the 
low level of infiltration detected in these animals 
(Fig. 3F). On the contrary, the up-regulation of pro-
inflammatory cytokines IL-6 and TNF-α was less 
pronounced than MCP-1 and comparable in the 
two strains, while levels of IL-1β, which is thought 
to contribute to the systemic effects of 
pancreatitis,[29] were higher in TPH1
-/-
 mice upon 
AP induction.  
Importantly, restoration of 5-HT levels in TPH1
-/-
 
mice via administration of the 5-HT precursor 5-
HTP, as previously described,[15] induced a robust 
leukocyte infiltration (Fig. S5A), increased MCP-1 
transcript levels (Fig. S5B) and promoted 
apoptosis of acinar cells (Fig. S5C) following 24h 
of cerulein treatment. These results confirmed that 
5-HT is a main factor promoting the recruitment of 
inflammatory cells and cellular damage in the 
pancreas following AP induction. 
Reduced availability of 5-HT exacerbates 
inflammatory and fibrotic processes during 
progression of pancreatitis. 
Next, we evaluated whether TPH1
-/-
 mice 
maintained a reduced inflammatory response also 
in the progression toward a chronic stage of the 
disease. Surprisingly, leukocyte infiltration was 
higher in TPH1
-/-
 animals compared with WT mice 
after two weeks of cerulein treatment (Fig. 4A), but 
no lethality was observed throughout the course of 
the experiment. Time-course analysis of 
chemokine/cytokine expression in the pancreas 
revealed that in WT animals all the mRNA tested 
peaked either at 24h (MCP-1, Fig. 3F) or three 
days (IL-6, Cox-2, IL-1β) after the beginning of 
cerulein treatment, and progressively decreased 
over time (Fig. 4B). On the other hand, in TPH1
-/-
 
mice the expression of MCP-1, IL-6, Cox-2 (Fig. 
4B) and macrophage F4/80 transcripts (Fig. 4C) 
were up-regulated after two weeks of treatment, 
when leukocyte infiltration increased. In addition, 
IL-1β levels, expressed also by acinar cells (Fig. 
S6), remained constantly higher in TPH1
-/-
 animals 
during the entire time course of experimental 
pancreatitis (Fig. 4B).  Moreover, cellular damage 
assessed by histological score was not reduced 
(Fig. S7), suggesting that the 5-HT-mediated 
protection observed during AP may be transient. 
Finally, we evaluated whether the absence of 
peripheral 5-HT modulated the development of 
fibrosis in the pancreas, a process mediated by 
activated pancreatic stellate cells. Similar to the 
observations of pro-inflammatory genes, 
expression of TGF-β, one of the most potent 
fibrogenic stimuli described for pancreatic stellate 
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cells, [30] increased in WT mice in the early phase 
of pancreatitis induction and decreased after two 
weeks of cerulein treatment (Fig. 5). On the 
contrary, TPH1
-/-
 mice showed increased TGF-β, 
α-smooth muscle actin (αSMA) and collagen 
transcripts at the later time point, suggesting 
increased induction of fibrosis in these animals.  
Interestingly, administration of the 5-HT precursor 
5-HTP for two weeks did not trigger inflammation 
when administered alone but worsened the 
inflammatory and fibrotic processes during  
cerulein treatment in WT mice to levels observed in 
TPH1
-/-
 animals (Fig. S8). These results not only 
support the pro-inflammatory role of 5-HT, but also 
reveal the fine balance between circulating 5-HT 
levels and 5-HT-dependent modulation of 
physiopathological effects. 
Reduced availability of 5-HT promotes acinar 
cell damage upon supramaximal cerulein 
stimulation. 
As lack of peripheral 5-HT was associated with 
more severe progression of pancreatitis, we 
evaluated whether the observed impaired 
zymogen secretion led to intracellular zymogen 
accumulation and increased cytotoxicity following 
prolonged cerulein treatment. Acinar cells of TPH1
-
/-
 mice showed increased amylase levels (Fig. 6A) 
and necrosis (Fig. 6B) following two weeks cerulein 
treatment compared with WT animals. In addition, 
trypsinogen activation, an event mediating the 
initial pancreatic injury but not inflammation 
following supramaximal cerulein stimulation,[31] 
was observed earlier in TPH1
-/-
 mice during the 
acute phase of experimental pancreatitis (Fig. 6C). 
To further test whether intracellular zymogen 
accumulation increases the sensitivity of acinar 
cells to cerulein-mediated toxicity, we treated 
dexamethasone-differentiated AR42J cells first 
with fluoxetine for 24h and then with supra- and 
submaximal cerulein concentrations for additional 
24h. In support of our hypothesis, we found that 
fluoxetine treatment decreased AR42J viability only 
in presence of supramaximal cerulein 
concentration (Fig.6D). 
Discussion 
The role of 5-HT and 5-HT-dependent pathways 
outside the central nervous system is now the 
subject of increasing interest, as recent studies 
highlighted its involvement in the physiology and 
pathology of several organs [32]. In this study we 
explored the role of 5-HT in pancreas physiology 
and during development of pancreatitis, a highly 
debilitating and potentially lethal disease whose 
pathophysiology remains undefined. Our work 
using transgenic mice genetically deficient in 
peripheral 5-HT revealed a 5-HT-mediated 
modulation of zymogen secretion in pancreatic 
acinar cells and demonstrated a dual role of 5-HT 
in the onset and establishment of pancreatitis. 
5-HT and the onset of pancreatitis 
Pancreatic damage following deregulated 
zymogen secretion and leukocyte infiltration are 
characteristic early events in acute pancreatitis.[3, 
33] In the present study we observed that both 
parameters markedly decreased in TPH1
-/-
 mice 
and were restored following 5-HTP 
supplementation, indicating that peripheral 5-HT is 
a potent activator of tissue damage and 
inflammatory response at the onset of pancreatitis. 
Early studies using pharmacological modulation of 
5-HT pathways in rodents suggested that 5-HT 
may be involved in the development of 
pancreatitis. Specifically, lowering the endogenous 
5-HT levels by temporarily inhibiting 5-HT 
synthesis or following depletion of platelets, the 
major store of circulating 5-HT, reduced the 
damage and inflammation of experimental acute 
pancreatitis.[34, 35] Moreover, administration of 
selective agonists and antagonists of different 5-
HT receptors showed aggravating and protective 
effects, respectively, in the context of both acute 
and chronic pancreatitis, albeit discrepancies 
resulting from varying binding affinities and 
potentially undefined side effects of the used 
compounds were observed.[34, 36, 37, 38, 39]  
While these studies supported the hypothesis that 
5-HT exacerbates pancreatitis via specific 
receptor-mediated pathways, the exact 
mechanisms of 5-HT modulation of the disease 
were not identified. As 5-HT has been shown to 
directly activate and induce the production of pro-
inflammatory cytokines in isolated immune cells 
(reviewed in [40, 41]), it is likely that the absence of 
peripheral 5-HT directly hampered leukocyte 
activation also in our experimental model. 
However, it is possible that 5-HT affected the 
production of immune-mediators also in non-
leukocytic cells, including pancreatic acinar cells. 
Indeed, the CC chemokine MCP-1, which showed 
the highest up-regulation in WT animals during 
pancreatitis and only moderate transcription in the 
absence of 5-HT, is produced also by acinar cells 
(reviewed in [42]). The critical role of MCP-1 as an 
early inflammatory mediator driving leukocyte 
chemotaxis into the injured pancreas was revealed 
by Bhatia and colleagues.[43] Importantly, despite 
the fact that MCP-1 is regarded as an activator of 
monocytes, recent studies suggested that this 
chemokine is also promoting the recruitment of 
neutrophils during the course of pancreatitis and 
colitis,[43, 44] implicating a wide range of target 
cells responsive to the molecule. 
The pattern of pro-inflammatory processes we 
observed in our AP model suggested that the 
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reduction of pancreatic inflammation in TPH1
-/-
 
mice cannot be attributed to a general reduction of 
pro-inflammatory factors, but likely to an aberrant 
regulation of selected chemokines/cytokines. This 
complex scenario parallels the broad variety of 5-
HT-mediated effects, largely due to the presence 
of multiple receptor subtypes in different cell types. 
In particular, 5-HT was shown to display opposite 
effects on the production of cytokines with similar 
cellular functions (reviewed in [13, 41]). Of note, 
while 5-HT receptors have been characterized on 
the surface of peripheral lymphocytes, 
macrophages and dendritic cells, the expression of 
these receptors on neutrophils has not yet been 
described,[11, 40] suggesting that 5-HT 
modulation of these cells, as previously observed 
in a murine model of experimental colitis,[12] may 
be 5-HT receptor-independent and/or driven by 
other immune-modulators. 
In addition, 5-HT is likely to influence pancreatic 
inflammation via its vasoactive properties. In this 
regard, increased serum levels of 5-HT metabolites 
were detected following AP.[37] These 
metabolites, which are potent activators of platelet 
aggregation, vasoconstriction and reduced tissue 
microcirculation, are thought to impair pancreatic 
microcirculation, which is recognized as one of the 
etiological events of AP.[45, 46] Conversely, 
absence of 5-HT would maintain normal 
microcirculation properties during inflammatory 
injuries, as it was recently shown in TPH1
-/-
 
animals during challenge with experimental 
hepatitis.[47] 
Finally, a novel receptor-independent mechanism 
identified in our study by which 5-HT could 
modulate the development of pancreatitis is the 
regulation of cellular secretion. We showed both in 
vitro and in vivo that reduced availability of 5-HT 
modulated actin cytoskeleton dynamics prevented 
the aberrant re-localization of zymogen granules 
and decreased amylase secretion, potentially 
limiting the initial magnitude of the 
immunoresponse. In addition to the observed 
reduction of zymogen secretion, it is tempting to 
speculate that absence of 5-HT may also reduce 
the efficiency of cytokine/chemokine secretion both 
in leukocytes and acinar cells, thus contributing to 
the limited inflammation observed in TPH1
-/-
 
animals. Moreover, an additional factor that could 
contribute to the differential development of AP 
and warrant of further investigation is the possible 
alteration in ductal secretion, as 5-HT was shown 
to inhibit fluid secretion in guinea pigs, albeit at 
supraphysiological concentration. [48]     
As previously mentioned, TPH1
-/-
 animals have 
impaired insulin secretion by β-
mild diabetes which worsens during aging (70 
weeks), but neither reduces life expectancy nor 
causes morbidity.[15] Currently, we do not have 
evidences for a role of diabetes in the development 
of pancreatitis observed in TPH1
-/-
 mice. Indeed, 
while diabetes has been shown to aggravate 
cerulein-induced pancreatitis by increasing 
inflammation during the acute phase and 
promoting metaplasia,[49] these events were not 
observed in our experimental model. 
We are currently focusing on identifying the 
molecular targets of 5-HT controlling acinar cell 
secretion. Our results demonstrating that 
intracellular 5-HT is required for zymogen 
exocytosis suggested that serotonylation of 
intracellular proteins is required for optimal 
zymogen secretion, as previously observed for 
serotonylated small GTPases of the Rab family in 
pancreatic β-cells and platelets.[14, 15] While Rab 
GTPases, central regulators of vesicle budding, 
motility and fusion in eukaryotic cells, are likely to 
be involved in acinar cells zymogen secretion, our 
results showing 5-HT modulation of actin–based 
processes suggest that serotonylation of proteins 
regulating cellular cytoskeleton dynamics, including 
members of the Rho family, may  contribute as well  
to zymogen secretion in acinar cells.   
5-HT and progression of pancreatitis 
Our AP data and a recent study on the 
pathogenesis of experimental colitis,[12] highlight a 
possible general involvement of 5-HT in the 
development of inflammatory diseases and support 
the therapeutic potential of agents interfering with 
5-HT-mediated pathways. However, when we 
monitored the progression of pancreatitis toward a 
chronic state, we found that the blunted response 
in the absence of 5-HT was transient and 
exacerbated in TPH1
-/-
 mice after two weeks of 
cerulein treatment. Hence, these results indicated 
that the immune response does not completely rely 
on 5-HT-mediated mechanisms, but it is likely to 
activate compensatory mechanisms at later stages 
of the disease. 
The molecular mechanisms leading to the 
increased cellular damage in TPH1
-/-
 mice after two 
weeks of cerulein treatment remain to be 
determined. One possibility highlighted by our 
results is that a prolonged impairment of zymogen 
secretion is toxic to acinar cells. In this context, the 
observed higher number of necrotic acinar cells in 
TPH1
-/-
 may constitute a trigger for a necrosis-
fibrosis sequence, as described for chronic 
pancreatitis.[50, 51] As typical hallmarks for this 
process we detected macrophage recruitment and 
up-regulation of TGF-β expression, stellate cell 
activation and extracellular matrix markers in 
TPH1
-/-
 animals, indicating an increased 
fibrogenesis in our experimental system.  
Alternatively, increased cellular damage could 
derive from impaired regeneration of acinar cells in 
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absence of 5-HT, as previously observed in the 
case of hepatocytes following experimental 
hepatectomy.[8] Indeed, we observed that cell cycle 
activation in acinar cells was altered in TPH1
-/-
 mice 
following cerulein-induced pancreatitis (Saponara et 
al., in preparation).  
In conclusion, our data directly link 5-HT to the 
pathophysiology of cerulein-induced pancreatitis 
and provide a mechanistic explanation for the 
reduced acute stage of the disease observed in 
absence of 5-HT. These findings underline the 
involvement of 5-HT in the secretory processes of 
pancreatic acinar cells and in the regulation of pro-
inflammatory mediators and subsequent 
progression of inflammatory diseases. Collectively, 
our data not only support the potential of 
therapeutic strategies based on 5-HT-mediated 
pathways during pathological inflammatory events, 
but also contribute to the elucidation of cellular 
processes in the exocrine pancreas. 
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Figures  
 
 
Figure 1. 5-HT modulates zymogen secretion in pancreatic acinar cells. A. Isolated acini were fixed and stained with an anti-
amylase antibody (yellow). Nuclear DNA was stained with DAPI (blue). Note the accumulation of amylase containing vesicles in 
TPH1
-/-
 acini. Scale bars: 50 µM. B. Amylase content in WT and TPH1
-/-
 acini normalized by protein amount. C. Isolated acini were 
treated with cerulein at the indicated concentrations for 60 min and basal and cerulein-induced amylase secretion was normalized 
by protein amount. Note the reduced amylase secretion in stimulated TPH1
-/-
 acini. D. AR42J cells were treated for 5h with 20 µM 
-methyl-5-HT (aMe), 10 mM HTR1B antagonist GR127935 (1B), 10 µM HTR2B 
antagonist LY266097 (2B) or solvent (Cntl). Basal and cerulein-induced amylase secretion was expressed as percent of control-
treated cells. E. Confocal microscopy of AR42J cells treated for 5h with 20 µM fluoxetine (Fl) and stained with an anti-amylase 
antibody (green). Nuclear DNA was stained with DAPI (blue). Note the accumulation of amylase-containing vesicles upon fluoxetine 
treatment. Scale bars: 10 µM. Results are average ± SEM (n=3), *p<0.05.  
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Figure 2. 5-HT modulates cytoskeleton dynamics in pancreatic acinar cells. A. Visualization of zymogen granules in control and 
treated mice harvested 24h after the first cerulein injection showed increased apical to baso-lateral granule re-localization in WT 
animals (arrows). Scale bars: 50 µM. Rac1 (B) and actin (C) staining in control and treated mice harvested 8h after the first 
cerulein injection. Note the different dynamic of baso-lateral staining (arrows) in absence of 5-HT. Insets, merge pictures with 
DAPI nuclear staining. Scale bars: 50 µM D. Left panel. Bleb formation in AR42J cells treated for 30 min with 10 nM cerulein or 
1 µM jasplakinolide (Jas) was prevented by 5h pre-treatment with 20 mM fluoxetine (Fl). Right panel: enumeration of bleb 
forming cells following 1 µM jasplakinolide treatment (Jas) in presence or absence of 20 mM fluoxetine (Fl). Results are 
expressed as percentage of total cell number ± SEM (n=3), *p<0.05.  
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Figure 3. Lack of 5-HT limits damage and leukocyte infiltration during AP. A. Serum levels of amylase increased more in WT than 
TPH1
-/-
 mice during cerulein treatment. B. Staining with the pan-leukocyte marker coronin-1 revealed higher leukocyte infiltration in 
pancreas of WT mice compared with TPH1
-/-
 animals. Insets, enlarged view of infiltrating cells shown by frame. Scale bars: 50 µM. 
C. Quantification of Ki67 positive infiltrating and pancreatic acinar cells. D. Quantification of infiltrating cells expressing PU.1, F4/80, 
HO-1, CD3 in pancreas. E. Quantification of MPO levels in the pancreas.  F. qRT-PCR of chemokine/cytokine levels in the 
pancreas. Note the limited up-regulation of MCP-1 in TPH1
-/-
 animals. Results are average ± SEM (n=5), *p<0.05.  
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Figure 4. Lack of 5-HT exacerbates inflammatory processes after two weeks of cerulein treatment. A. Staining with the pan-
leukocyte marker coronin-1 revealed higher leukocyte infiltration in the pancreas of TPH1
-/-
 animals. Scale bars: 50 µM. qRT-PCR 
showed up-regulation of chemokine/cytokine levels (B) and macrophage-specific antigen F4/80 (C) in the pancreas of TPH1
-/-
 mice 
after two weeks of cerulein treatment. Results are average ± SEM (n=5), *p<0.05.  
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Figure 5. Lack of 5-HT exacerbates fibrotic processes after two weeks of cerulein treatment. qRT-PCR quantification of TGF-β, 
α-smooth muscle actin (αSMA) and collagen transcripts indicated increased activation of fibrotic processes in TPH1
-/-
 mice after 
two weeks of cerulein treatment. Results are average ± SEM (n=5), *p<0.05.  
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Figure 6. Lack of 5-HT promotes acinar cell damage upon supramaximal cerulein stimulation. A. Amylase immunostaining (left 
panel) and transcript expression (right panel) after two weeks of cerulein treatment.B. Quantification of apoptotic and necrotic 
pancreatic acinar cells after two weeks of cerulein treatment. C. Quantification of trypsinogen activation after one and eight hours of 
cerulein treatment. D. Dexamethasone-differentiated AR42J cells were treated for 24h with solvent (Cntl) or 20 µM fluoxetine (Fl) 
followed by  supramaximal (100 nM) and submaximal (100 pM) cerulein  or saline control (NaCl) for additional 24h. Their viability 
was assessed by measuring metabolic activity through reduction of MTT and expressed as % of control treated cells. Results are 
average ± SEM (n=5), *p<0.05. 
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Supplementary Materials and Methods 
Materials and Methods 
Biochemical reagents 
Unless otherwise stated, all chemicals were purchased from Sigma and cell culture reagents from 
Gibco-BRL. Reagents stock solutions were prepared at the following concentrations in 0.9% NaCl: 50 
mM cysteamine, 0.37 mM cerulein, 5 mg/mL 5-hydroxy-L-tryptophan (5-HTP), 33 mM α-methyl-5-HT, 
10 mM HTR2B (LY266097,Tocris Bioscience, Bristol, UK), 10 mM HTR1B (GR127935, Tocris 
Bioscience, Bristol, UK), 5.8 mM fluoxetine. 100 µM Jasplakinolide was prepared in DMSO. 
Mammalian cell culture 
AR42J cells were maintained in Kaighn’s modified Ham’s F-12 medium with 20% fetal bovine serum 
(FBS), 50 U/mL penicillin, and 50 µg/mL streptomycin at 37°C in a 5% CO2 atmosphere. Cell 
metabolic activity was tested with 0.5% tetrazolium salt solution 3-(4,5- dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT), according to the manufacturer’s instructions. 
Biochemical analysis of blood 
For determination of pancreatic enzymes present in the serum, blood was sampled by heart puncture 
and amylase and lipase levels were measured using the Cobas c111 spectrophotometer (Roche 
Diagnostic GmbH, Mannheim, Germany). LDH levels were measured using the Fuji Dri-Chem 4000i 
analyzer.  
5-HT assay 
5-HT quantification in plasma was performed using a 5-HT ELISA kit (Griffin Life Science, Abington, 
UK), according to the manufacturer’s instructions. 
Histology and immunohistochemistry  
Pancreas and spleen specimens were embedded in paraffin or OCT for histological analyses as 
described.[1] For immunofluorescence analysis of cultured cell lines, AR42J cells were fixed in 3.6% 
formaldehyde and permeabilized with 0.2% Triton X-100 in PBS. Primary antibodies used in this study 
were: Alexa Fluor 594 phalloidin (Life Technologies, Zug, Switzerland), rabbit anti-amylase (Sigma-
Aldrich, Buchs, Switzerland), mouse anti-Rac1, rabbit anti-IL-1β, rat anti-F4/80, rabbit anti-HMGB-1 
(Abcam, Cambridge, UK), rabbit anti-PU.1 (Cell Signaling Technologies, Danvers, MA), rabbit anti-
coronin-1 [2], rabbit anti-Ki67 (Abcam, Cambridge, UK), rabbit anti-CD3 and rabbit anti-HO-1 (Assay 
Designs, Ann Arbor, USA). Fluorophore-conjugated secondary antibodies were used at 1:200 dilution. 
Nuclei were visualized with 4′, 6-diamidino-2-phenylindole (DAPI). 
Detection of DNA fragmentation in apoptotic cells was performed with a TUNEL assay using an 
ApopTag peroxidase Kit (MP Biomedicals, Illkirch, France). 
Microscopy analyses were performed on a Zeiss Axioplan 2 Imaging fluorescence microscope (Carl 
Zeiss Microimaging, Göttingen, Germany) or on a Leica SP2 AOBS confocal laser-scanning 
microscope (Leica Microsystems, Wetzlar, Germany), using the appropriate settings. Image stacks of 
optical sections were further processed using the Huygens deconvolution software package version 
2.7 (Scientific Volume Imaging, Hilversum, NL). 
MPO assay 
10 mG frozen pancreatic tissue was homogenized in 200 µL cold lysis buffer (200 mM NaCl, 5 mM 
EDTA, 10 mM Tris, 10% glycerol, 1mM PMSF, complete protease inhibitor, pH 7.4). Myeloperoxidase 
activity in the supernatant was measured using the Mouse MPO ELISA Kit (HBT, Hycult Biotech, 
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Uden, The Netherlands), according to the manufacturer’s instructions. Measured MPO levels were 
normalized by protein concentration. 
Malondialdehyde level determination 
Free malondialdehyde (MDA) levels in pancreas tissues were quantified using a MDA-586 colorimetric 
assay kit (Oxis International Inc., CA, USA) according to the manufacturer instructions. Briefly, frozen 
pancreata were homogenized in presence of butylated hydroxytoluene at a concentration of 0.1 
mg/µL. Measured MDA levels were normalized by protein concentration. 
Transcript analysis 
The following Taqman probes (Applied Biosystems) were used: F4/80-Emr1 Mm00802530_m1, 
MCP1/CCL2 Mm00441242_m1, IL-6 Mm00446190_m1, IL-1β Mm00434228_m1, TNFα 
Mm00443258_m1, COX-2 Mm00478374_m1, TGFβ Mm00441724_m1, αSMA Mm01546133_m1, 
collagen type IV, α1 Mm01210125_m1, amylase 1 Mm00651524_m1. 
Trypsin activity assay 
20 mG frozen pancreatic tissue was homogenized in 250 µL cold MOPS buffer (250 mM sucrose, 5 
mM MOPS, 1 mM Mg SO4, pH 6.5) using the Precellys® 24 tissue homogenizer. Trypsin activity was 
measured flourometrically at 37°C in 250 µL trypsin assay buffer (50 mM Tris, 150 mM NaCl, 1 mM 
CaCl2, 0.1% BSA, pH 8.0) containing 250 µg supernatants and 40 µM Boc-Glu-Ala-Arg-MCA 
(Bachem, Bubendorf, Switzerland) as a substrate, as described [3]. The fluorescence emitted at 440 
nm in response to excitation at 380 nm was monitored over a 10 min period. 
Statistical analyses 
Groups of 5 animals were tested for each experiment. The data are expressed as the means ± SEM. 
The statistical significance of differences in the means of experimental groups was determined using 
an unpaired, two-tailed Student's t test or one-way analysis of variance (GraphPad Prism 4.0c; 
GraphPad Software, Inc.), and a probability value <0.05 was considered statistically significant. When 
the overall probability value was <0.05, the Dunnett multiple-comparisons test was used as a post-test 
to determine whether there was a significant difference between values of control (reference sample) 
and samples of interest.  
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Figures 
Figure S1. Content of 5-HT in platelet-rich plasma in WT and TPH1
-/-
 mice. Results are average ± SEM (n=3), *p<0.05. 
Figure S2. Fluoxetine does not reduce AR42J cell viability.  AR42J cells were treated for 48h with solvent (Cntl) or fluoxetine 
(Fl) at the indicated concentrations and their viability was assessed by measuring metabolic activity through MTT reduction. 
Results are average ± SEM (n=4). 
 
Figure S3. Lack of 5-HT limits leukocyte infiltration during cerulein-induced AP. WT and TPH1
-/-
 mice were harvested 24h after 
the first cerulein injection. Staining with the pan-leukocyte marker coronin-1 revealed higher leukocyte infiltration in spleen of WT 
mice compared with TPH1
-/-
 animals. Scale bars: 50 µM. 
 
 
Figure S4. Lack of 5-HT does not change lipid oxidation levels. Malondialdehyde (MDA) levels were quantified in pancreatic 
tissue 24h after initial cerulein injection in WT and TPH1
-/-
 mice using a MDA-586 colorimetric assay kit (Oxis International Inc., 
CA, USA) and normalized by protein concentration. Results are average ± SEM (n=5). 
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Figure S5. 5-HTP administration to TPH1
-/-
 mice restores leukocyte infiltration during AP. A. Staining with the pan-leukocyte 
marker coronin-1 showed increased leukocyte infiltration in the pancreas upon 5-HTP treatment. Scale bars: 50 µM. B. qRT-
PCR of chemokine/cytokine levels in the pancreas after 5-HTP supplementation. Values of control and cerulein-treated WT and 
TPH1
-/-
 mice are shown as comparison. Results are average ± SEM (n=5).C. TUNEL staining showed increased number of 
apoptotic acinar cells in 5-HTP-treated TPH1
-/-
 mice compared with WT animals following cerulein injections (5-HTP+cer). 
Results are average ± SEM (n=5), *p<0.05. 
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Figure S6. Cerulein treatment increase IL-1β production in acinar cells. TPH1
-/-
 mice were injected repetitively with cerulein and 
harvested two weeks after the first injection. IL-1β staining showed increased cytokine content in acinar cells (A) and spleen (B). 
 
Figure S7. Lack of 5-HT does not limit cellular damage during cerulein-induced CP. WT and TPH1
-/-
 mice were injected 
repetitively over two weeks with cerulein and harvested one and two weeks after the first injection. A. Histological score showing 
comparable levels of tissue damage in the two animal strains. B. Hematoxylin-eosin (H&E)-stained sections of pancreas after 
two weeks of cerulein-treatment. Arrowheads indicate regions of tissue damage. Scale bars: 50 µM 
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Figure S8. 5-HTP administration increases inflammatory and fibrotic processes during two weeks cerulein treatment. A. 
Staining with the pan-leukocyte marker coronin-1 showed increased leukocyte infiltration in the pancreas of WT and TPH1
-/-
 
mice upon 5-HTP+cerulein treatment. Scale bars: 50 µM. qRT-PCR of chemokine/cytokine levels (B) and fibrotic markers (C) in 
the pancreas after two week cerulein treatment with or without 5-HTP supplementation. Values of control and cerulein-treated 
WT and TPH1
-/-
mice are shown as comparison. Results are average ± SEM (n=5). 
 
47 
 
6. Manuscript B 
 
Serotonin promotes acinar de-differentiation following pancreatitis-
induced regeneration in the adult pancreas. 
Enrica Saponara1, Kamile Grabliauskaite1#, Marta Bombardo1#,  Raphael Buzzi1, Alberto B. 
Silva1, Ermanno Malagola1 Yinghua Tian1, Adrian B. Hehl 2, Elisabeth M. Schraner3, Gitta 
Seleznik1,  Anja Zabel1, Theresia Reding1, Sabrina Sonda1* and Rolf Graf1* 
# Contributed equally 
* Shared last authors 
1
Swiss Hepato-Pancreato-Biliary Center, Department of Visceral and Transplantation Surgery, University Hospital, Zurich 
 
2
Institute of Parasitology, University of Zurich
 
3
Institutes of Veterinary Anatomy and Virology, University of Zurich, Switzerland 
 
Published in Journal of Pathology 2015 
 
 
 
 
 
 
 
 
 
Contribution: This study represents a major part of my PhD work. All experimental work was 
done by me with the exception of confocal microscopy analysis performed by Prof. A. Hehl, 
electron microscopy performed by E. Schraner and pancreatic microsurgery performed by 
Prof. Y. Tian. Minor experiments were performed in collaboration with colleagues. I also 
contributed to drafting/revising of large parts of the manuscript. 
  
48 
 
Serotonin promotes acinar de-differentiation following pancreatitis-induced 
regeneration in the adult pancreas. 
Enrica Saponara1, Kamile Grabliauskaite1#, Marta Bombardo1#,  Raphael Buzzi1, Alberto B. 
Silva1, Ermanno Malagola1 Yinghua Tian1, Adrian B. Hehl 2, Elisabeth M. Schraner3, Gitta 
Seleznik1,  Anja Zabel1, Theresia Reding1, Sabrina Sonda1* and Rolf Graf1* 
1Swiss Hepato-Pancreato-Biliary Center, Department of Visceral and Transplantation 
Surgery, University Hospital, Zurich; 2Institute of Parasitology, University of Zurich; 3Institutes 
of Veterinary Anatomy and Virology, University of Zurich, Switzerland 
Running title: serotonin and acinar cell de-differentiation 
# Contributed equally 
* Shared last authors 
 
Address correspondence to: 
Pancreatitis Research Laboratory  
Department of Visceral and Transplantation Surgery 
University Hospital Zurich, Rämistrasse 100, 8091 Zurich, Switzerland 
Tel.+41 44 255 33 55 
Sabrina Sonda; sabrina.sonda@usz.ch 
Rolf Graf; rolf.graf@usz.ch 
Competing interests: none 
Word count: 3814  
 
 
 
 
 
 
49 
 
Abstract 
 
The exocrine pancreas exhibits a distinctive 
capacity for tissue regeneration and renewal 
following injury. This regenerative ability has 
important implications for a variety of disorders, 
including pancreatitis and pancreatic cancer, 
diseases associated with high morbidity and 
mortality. Thus, understanding its underlying 
mechanisms may help develop therapeutic 
interventions. Serotonin has been recognized as 
a potent mitogen for a variety of cells and tissues. 
Here we investigated whether serotonin exerts a 
mitogenic effect in pancreatic acinar cells in three 
regenerative models, namely inflammatory tissue 
injury following pancreatitis, tissue loss following 
partial pancreatectomy and thyroid hormone-
stimulated acinar proliferation. Genetic and 
pharmacological techniques were used to 
modulate serotonin levels in vivo. Acinar de-
differentiation and cell cycle progression during 
the regenerative phase were investigated over 
the course of two weeks. By comparing acinar 
proliferation in the different murine models of 
regeneration, we found that serotonin did not 
affect clonal regeneration of mature acinar cells. 
However, it was required for acinar de-
differentiation following inflammation-mediated 
tissue injury. Specifically, lack of serotonin 
resulted in delayed up-regulation of progenitor 
genes, delayed formation of acinar-to-ductal 
metaplasia and defective acinar cell proliferation. 
We identified serotonin-dependent acinar 
secretion as a key step in the progenitor-based 
regeneration, as it promoted acinar cell de-
differentiation and the recruitment of type 2 
macrophages. Finally, we identified a regulatory 
Hes1-Ptfa axis in the uninjured adult pancreas 
activated by zymogen secretion. Our findings 
indicate that serotonin plays a critical role in the 
regeneration of the adult pancreas following 
pancreatitis by promoting de-differentiation of 
acinar cells.  
 
Keywords: serotonin; acinar secretion; de-
differentiation; regeneration; ADM; pancreatitis; 
partial pancreatectomy. 
 
Introduction 
Despite a low homeostatic turnover, the adult 
exocrine pancreas has the ability to regenerate 
following an inflammatory insult. An increasing 
number of reports have revealed that during this 
regenerative process acinar cells, which 
constitute the most abundant cell population of 
the exocrine tissue,  transiently de-differentiate 
and initiate a genetic program resembling the one 
found in embryonic pancreatic precursors 
(recently reviewed in [1,2]). Although numerous 
studies have identified crucial factors involved in 
the regeneration of acinar cells, the precise  
 
 
mechanisms initiating the cascade of events 
leading to their de-differentiation have not yet 
been identified. Serotonin (5-hydroxytryptamine, 
5-HT), a monoamine stored and released by 
circulating platelets, has long been recognized as 
a potent bioactive molecule with mitogenic effects 
not only during embryonic development [3,4] but 
also in adult cells [5]. Examples of the mitogenic 
role of 5-HT in adult tissues include liver 
regeneration following hepatectomy [6],   
megakaryocyte colony formation [7], pulmonary 
artery smooth muscle cell proliferation [8] and 
beta cell expansion during pregnancy [9].  
We recently showed that 5-HT plays a major role 
in the pathophysiology of the exocrine pancreas 
where it promotes acinar cell secretion and 
exacerbates the severity of inflammation at the 
onset of acute pancreatitis [10]. Here we 
investigated whether 5-HT acts as a mitogen for 
pancreatic acinar cells and thus promotes tissue 
regeneration. To this aim, we compared three 
types of regenerative stimuli, namely cerulein-
induced pancreatitis, partial pancreatectomy and 
thyroid hormone supplementation, in mice 
deficient in peripheral 5-HT (tryptophan 
hydroxylase 1 knocked-out, Tph1
-/-
), and in wild 
type mice supplemented with 5-HT precursor. 
 
Material and methods 
 
Animal experiments 
All animal experiments were performed in 
accordance with Swiss federal animal regulations 
and approved by the cantonal veterinary office of 
Zurich. Pancreatitis was induced in adult (8-10 
weeks of age) wild-type (WT) C57BL/6 (Harlan 
Laboratories, Horst, The Nederlands) and Tph1
-/-
 
mice on a C57BL/6 background [11], bred in our 
facility, via six intra peritoneal (i.p.) injections of 
50 g/kg cerulein administered hourly over a two 
week period, as described in Supplementary 
Materials and Methods and [12]. Pancreatectomy 
was performed according to [13], with the 
procedure adapted to remove 60% of the organ. 
400 g/kg 3,5,3-L-tri-iodothyronine (T3) was 
administered daily via i.p. injections for six days.  
20 mg/kg 5-hydroxytryptophan (5-HTP) was 
administered by two subcutaneous injections per 
day, 12 hours apart. The treatment was started 
one day before cerulein treatment; control 
animals received 0.9% NaCl injections.  
 
Histology, immunohistochemistry and 
immunoblotting 
Detailed protocols and primary antibodies used in 
this study are listed in Supplementary Materials 
and Methods. Quantification of labelled cells was 
performed in at least 10 randomly selected high-
power fields (×100) per slide. Non-acinar tissue 
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areas (islets, vessels, fibrotic tissue) were 
excluded from the analysis. 
 
Electron microscopy analysis 
WT and Tph1
-/-
 mice were harvested 8 hours 
after the beginning of cerulein treatment. Sliced 
pancreata were fixed in 2% glutaraldehyde/1% 
paraformaldehyde in 0.1M Na/K-phosphate pH 
7.4 for 90 min. After washing, the samples were 
postfixed with 1% osmium tetroxide in 0.1M 
Na/K-phosphate for one hour, dehydrated in a 
graded ethanol series, transferred to acetone for 
embedding in Epon and polymerized at 60°C for 
2.5 days. Ultrathin sections were stained with 
uranyl acetate and lead citrate and examined at 
an acceleration voltage of 100 kV in a Philips CM 
12 transmission electron microscope (Eindhoven, 
The Netherlands) equipped with a CCD camera 
(Ultrascan 1000, Gatan, Pleasanton, CA).  
 
Transcript analysis 
Total RNA was extracted from pancreata as 
previously described [14] and reverse transcribed 
with qScript™ cDNA SuperMix (Quanta 
Biosciences). Transcript levels were normalized 
using 18S rRNA as a reference and expressed 
as fold regulation relative to the value of 
untreated control animals. Taqman probes 
(Applied Biosystems) used in this study are listed 
in Supplementary Materials and Methods. 
 
Results 
 
Lack of 5-HT results in defective acinar cell 
proliferation and delayed ADM formation  
To test whether 5-HT is mitogenic for acinar cells, 
we compared acinar proliferation following 
induction of pancreatitis in WT and  in Tph1
-/-
 
mice, characterized by reduced 5-HT levels in the 
periphery but normal 5-HT signaling in the 
nervous system [10]. Unexpectedly, Tph1
-/- 
animals showed a significantly higher number of 
acinar cells positive for the general cell cycle 
activation marker Ki67 after one week of cerulein 
treatment compared with WT animals, while the 
number of bromodeoxyuridine (BrdU) positive 
cells in G1/S phase was similar in the two strains. 
Phospho-histone H3 (pH3) positive acinar cells in 
G2/M phase increased in Tph1
-/-
 mice only 14 
days after the beginning of the treatment (Fig. 
1A, S1A). Acinar and interstitial cells were 
distinguished based on nuclear size, shape and 
location, as shown in Fig. S1B, C. Quantification 
of acinar cells in G2 phase, displaying punctuate 
pH3 staining, and in mitotic phase, with 
homogeneous nuclear pH3 staining [15], showed 
a reduced transition into mitotic phase in Tph1
-/-
 
animals one week after induction of pancreatitis 
(Fig. 1B).  
In addition, formation of acinar-to-ductal 
metaplasia (ADM), a transient trans-
differentiation observed during pancreatitis-
induced regeneration, was delayed in Tph1
-/-
 
mice three days after induction of pancreatitis 
(Fig. 1C). The slower kinetics of ADM formation 
was not the result of defective expression or re-
localization of -catenin, a key a transcriptional 
activator promoting ADM formation [16]. -
catenin was similarly localized on the plasma 
membrane and nuclei of intact acinar cells in both 
strains (Fig. 1D) and was also found in ADM of 
WT animals and in the rare areas with reduced 
amylase content in Tph1
-/-
 mice (Fig. 1E, 
arrowheads). Seven days after induction of 
pancreatitis, mature clustered ductal structures 
were visible in Tph1
-/-
 mice and were similar to 
WT ADMs in terms of -catenin expression, Sox9 
up-regulation, amylase down-regulation and 
activation of Sma-positive stellate cells (Fig. 2A, 
S2). Taken together, these data indicate that, 
upon cerulein stimulation, Tph1
-/-
 acinar cells are 
able to initiate the cell cycle; however, they 
display defective cell cycle progression and 
delayed ADM formation.  
 
Lack of 5-HT delays acinar de-differentiation 
during pancreatitis 
Proliferation of pancreatic acinar cells is 
preceded by a temporary de-differentiation and 
up-regulation of markers normally associated 
with pancreatic ductal or progenitor cells [17]. 
Concomitant with reduced ADM formation, Tph1
-/-
 
mice showed delayed up-regulation of the ductal 
marker cytokeratin 19 (Ck19) three days after 
induction of pancreatitis (Fig. 2A, B). In addition, 
delayed up-regulation was also observed for 
several progenitor markers, including Sox9, 
Hes1, Notch1, Hnf1. Ductal and progenitor gene 
expression was higher in Tph1
-/-
 than in WT 
animals after 14 days of pancreatitis, with the 
exception of Aldh1, the expression of which was 
comparable in the two strains (Fig. 2A, B). 
Noteworthy, delayed progenitor gene up-
regulation in Tph1
-/-
 mice was not accompanied 
by defective down-regulation of genes typical of 
the differentiated state, such as secretory granule 
enzymes and transcription factors controlling 
acinar cell identity, such as Mist-1[18-20] (Fig. 
S3). These data indicate that WT and Tph1
-/-
 
mice responded equally to the cerulein stimulus 
by down-regulating genes specific to mature 
differentiated acinar cells. However, amylase 
content did not decrease in Tph1
-/-
 acini, as 
quantified by western blotting (Fig. 3A), 
enzymatic activity (Fig. 3B) and 
immunofluorescence analysis (Fig. 3C), 
indicating that down-regulation of zymogen 
transcripts was not sufficient to induce zymogen 
loss in these mice. Autophagy can reduce 
zymogen content by intracellular degradation 
[21]. However, autophagy was not differentially 
regulated in Tph1
-/-
 mice, as shown by 
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comparable processing of the autophagic protein 
LC3 (Fig. S4A). Similarly, autophagic marker p62 
[22] showed widespread expression in acini at 8 
hours and down-regulation one day after 
induction of pancreatitis in both strains (Fig. S4B, 
C).  
 
Increased zymogen secretion promotes 
acinar de-differentiation during acute 
pancreatitis 
An alternative cellular mechanism explaining 
zymogen loss observed in acinar cells following 
pancreatitis could be the secretion of zymogens 
into extracellular space. We previously showed 
that Tph1
-/-
 mice have impaired zymogen 
secretion [10]. This defective secretory process 
was further investigated at the ultrastructural 
level. Electron microscopy analysis revealed that 
zymogen granules were more tightly packed in 
Tph1
-/-
 than in WT mice, both in control and after 
cerulein treatment (Fig. 3D). Furthermore, size 
distribution analysis showed that granule size, 
comparable in the two strains in the untreated 
controls, increased after stimulation of secretion, 
indicative of granule swelling preceding content 
expulsion [23]; however, the enlargement was 
higher in Tph1
-/-
 (Fig. 3E), presumably a 
consequence of impaired secretion. Thus, our 
results show that reduced zymogen secretion 
observed in the absence of 5-HT is associated 
with defective zymogen loss followed by delayed 
up-regulation of progenitor genes. To test 
whether 5-HT-dependent zymogen secretion is 
required to initiate acinar de-differentiation 
following pancreatitis, we increased zymogen 
secretion 24 hours before cerulein administration 
by treatment with 5-hydroxytryptophan (5-HTP) 
(regimen scheme depicted in Fig. 4A), a 
precursor of serotonin that dose-dependently 
stimulates apical secretion of zymogens into 
pancreatic ducts (reviewed in [24]). This 
stimulated secretion is associated with a 
protective effect during induction of acute 
pancreatitis [25-27]. Under 5-HTP 
supplementation and one day of pancreatitis, we 
also observed lower levels of inflammatory 
infiltrates in the pancreas (Fig. 4B), chemokine 
expression (Fig. 4C) and serum amylase (Fig. 
4D), likely due to the increased 5-HTP-stimulated 
apical secretion counteracting the aberrant baso-
lateral secretion induced by cerulein. The 
reduced severity of the disease did not translate 
in reduced acinar cell de-differentiation, as 5-
HTP+cerulein-treated mice showed robust 
amylase loss in the pancreas similar to cerulein-
treated mice (Fig. 4E). In addition, these mice 
had increased RNA levels of progenitor gene 
Hes-1 (Fig. 4F) and earlier expression of Sox-9 in 
acinar cell nuclei (Fig. 4G). These results suggest 
that stimulation of zymogen secretion enhances 
acinar de-differentiation following induction of 
pancreatitis. However, despite reducing the initial 
inflammation, one set of 5-HTP supplementation 
(regimen scheme depicted in Fig. S5A) was not 
sufficient to promote pancreatic regeneration, as 
shown by comparable levels of acinar and 
interstitial cell replication (Fig. S5B) and 
inflammatory cell infiltration (Fig. S5C) three days 
after induction of pancreatitis. In addition, 
increasing the dose of 5-HTP supplementation 
stimulated the expression of progenitor (Fig. 
S5D) and inflammatory genes (Fig. S5E) 
compared to one set of 5-HTP. 5-HTP 
supplementation over 14 days further boosted 
the up-regulation of inflammatory genes (Fig. 
S5F), and resulted in an increased trend of acinar 
cell replication (Fig. S5G), ADM formation (Fig. 
S5H) and inflammatory infiltration (Fig. S5I), 
suggesting that supplementation with exogenous 
5-HTP did not ameliorate disease progression. 
 
Lack of 5-HT delays the expression of MMPs 
during pancreatitis 
As inflammatory cells play an active role in ADM 
formation, we then tested the level of pancreatic 
inflammation in the two strains. Tph1
-/-
 mice 
showed reduced inflammation after one [10] and 
three days of pancreatitis (Fig. 4H, S6A). At this 
time point, expression of type-2 macrophage 
markers Mgl1 and Mrc1 was also reduced in 
Tph1
-/-
 mice, while the type-1 marker Nos2 was 
comparable in the two strains (Fig. 4I), 
Macrophage marker expression increased in 
Tph1
-/-
 mice at later time points (Fig. S6B). 
Cytokines secreted by macrophages stimulate 
matrix metalloproteinase (MMP) synthesis and 
secretion in acinar cells, thus driving digestion of 
extracellular matrix and ADM formation [28]. 
Concomitant with reduced macrophage 
infiltration, Tph1
-/-
 mice showed a reduced trend 
of Mmp7 (Fig. 4J) and Tnf expression (Fig. 
S6C).  
Then we digested the pancreatic extracellular 
matrix with collagenase and compared de-
differentiation of isolated acini after culture in 
suspension for 24 hours, as described [29]. In 
this in vitro setting, de-differentiation was similar 
in WT and Tph1
-/-
 acini, with or without 
exogenous 5-HT added to the medium (Fig. 4K), 
suggesting that the 5-HT mediated effect is 
exerted up-stream of extracellular matrix 
digestion.  
Analysis of vascular associated factors, including 
CD146 and VEGF, did not show alterations in the 
two strains after three days of pancreatitis, when 
the major ADM difference was observed, but their 
expression remained elevated in Tph1
-/-
 mice 
after 14 days of the disease (Fig. S6D). 
 
Lack of 5-HT does not alter clonal 
regeneration of acinar cells following partial 
pancreatectomy and T3 administration. 
52 
 
As we found that 5-HT supports progenitor-based 
regeneration following pancreatitis, we then 
investigated whether zymogen secretion is also 
required for pancreatic regeneration that does not 
depend on robust acinar de-differentiation and 
activation of progenitor genes. To this aim, we 
analyzed acinar replication following 60% partial 
pancreatectomy (PPX) that triggers a 
regenerative response preferentially based on 
clonal division of differentiated acinar cells.  
Acinar replication, albeit lower than the one 
induced after pancreatitis at all the time points 
analyzed, peaked one week following PPX (Fig. 
5A). Importantly, Tph1
-/- 
mice did not show 
accumulation of Ki67 positive acinar cells (Fig. 
5A, B). The replication peak was not preceded by 
robust expression of progenitor genes, the up-
regulation of which was lower than during 
pancreatitis and comparable in the two strains, 
with the exception of Hes1 that increased at the 
two week time point only in WT mice (Fig. 5C). In 
addition, pancreata isolated after pancreatic 
resection showed comparable amylase content 
(Fig. 5D) and minimal levels of inflammation, 
apoptosis and fibrosis in the two strains (Fig.S7A-
C). To test the effect of 5-HT in another model of 
inflammation-independent regeneration, we 
induced acinar proliferation by administering the 
thyroid hormone 3,5,3-L-tri-iodothyronine (T3) 
[30,31]. T3 treated WT and Tph1
-/-
 mice showed 
similar levels of acinar replication (Fig. 5E) and 
minimal leukocyte infiltration (Fig. 5F). 
Collectively, these data revealed that acinar 
replication following PPX and T3 administration is 
not affected by the lack of 5-HT.  
 
5-HT receptors are up-regulated during 
pancreatic regeneration 
As 5-HT signals via specific 5-HT receptors and 
transporter, we then compared their expression 
during pancreatic regeneration. Type 1 and 2 
receptors, known to play a role in regeneration of 
liver and heart [6,32,33] and found up-regulated 
in pancreatic cancer [34], were up-regulated 
following pancreatitis in WT mice and showed a 
delayed kinetic in Tph1
-/- 
animals (Fig. S8A). 
Analysis of samples with reduced inflammation, 
such as Tph1
-/- 
and 5-HTP supplemented WT 
mice one day after pancreatitis, indicated that 
inflammatory cells substantially contribute to the 
observed level of receptor expression, except in 
the case of 5-HT2A (Fig. S8B). Similarly, PPX 
samples, characterized by minimal tissue 
inflammation, showed lower 5-HT receptor and 
transporter expression compared with 
pancreatitis specimens (Fig. S8C). Interestingly, 
expression of 5-HT2B robustly increased in WT 
mice 14 days after PPX. 
To test whether acinar cells also express 5-HT 
receptors and transporter, we isolated pancreatic 
acini one day after pancreatitis induction. In WT 
acinar cells, expression of 5-HT receptors, but 
not transporter, increased upon disease 
induction. Tph1
-/- 
acini had an opposite trend of 
receptor expression compared with WT cells, 
showing lower type 1 and higher type 2 receptor 
levels (Fig. S8D). Collectively, these results 
indicate that pancreatic regeneration is 
associated with up-regulation of 5-HT receptors 
and transporter, which can be expressed not only 
by infiltrating cells but also by pancreatic acini. 
 
Hes1-Ptf1a axis is activated in the uninjured 
adult pancreas 
As we observed that 5-HTP treatment enhanced 
acinar de-differentiation following induction of 
pancreatitis (Fig. 4E, F), we then tested whether 
this regulation was observed also in the absence 
of tissue damage.  5-HTP-treated WT mice had 
normal levels of serum and tissue amylase (Fig. 
4C, D) and no Sox9 expression in acinar cells 
(Fig. 6A), suggesting that increased secretion 
into ducts is not sufficient to activate acinar de-
differentiation. However, 5-HTP treatment 
increased the expression of the progenitor gene 
Hes1 in the pancreas (Fig. 6B), albeit at a lower 
level than following 5-HTP+cerulein treatment. 
Hes1 is a critical orchestrator of pancreatic 
embryogenesis (reviewed in [35]),  as it  
regulates maintenance of progenitor cells and 
timing of cell differentiation by antagonizing the 
function of Ptf1a, a basic helix-loop-helix
 
transcription factor that promotes zymogen 
synthesis [36]. Hes1 up-regulation following 5-
HTP treatment was concomitant with Ptf1a down-
regulation (Fig. 6B). Moreover, early time points 
following cerulein treatment showed initial Ptf1a 
up-regulation followed by Hes1 expression and 
subsequent Pft1a down-regulation. 24 hours after 
induction of pancreatitis, Ptf1a levels were higher 
in Tph1
-/- 
mice with delayed Hes1 up-regulation 
(Fig. 6C). This suggests that the inhibitory 
function of Hes1 on Ptf1a expression described 
during development may be active also in the 
adult pancreas. We further explored the Hes1-
Ptf1a regulation in an in vitro system where the 
acinar cell line AR42J was stimulated toward a 
more differentiated and secretory phenotype by 
treatment with dexamethasone [37]. 48 hours of 
dexamethasone treatment changed the cell 
morphology from a more spheroid to flattened 
shape (Fig. S9A), led to decreased replication of 
AR42J cells (Fig. S9B), increased amylase 
content (Fig. 6D) and decreased Sox-9 
expression (Fig. 6E). Similar to what we 
observed in vivo, AR42J differentiation showed 
an initial increase of Ptf1a expression that was 
then reduced following Hes1 up-regulation (Fig. 
6F). 
Taken together, the in vivo and in vitro results 
presented here show that conditions of increased 
zymogen secretion and synthesis in acinar cells 
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are associated with the activation of the Hes1-
Ptf1a axis. These data not only indicate that 
different progenitor genes are regulated in a 
different manner in acinar cells, but also that the 
Hes1-Ptf1a axis may contribute to maintain 
physiological zymogen levels in the adult 
pancreas in the absence of acinar cell damage. 
 
Discussion 
 
The remarkable regenerative capacity observed 
in organs of several non-mammalian vertebrates 
often involves the de-differentiation of mature 
cells (reviewed in [38]). Notably, cell de-
differentiation is also observed in the 
regeneration of the adult exocrine pancreas of 
mammals following pancreatitis. In this organ, 
differentiated acinar cells transiently revert into a 
progenitor state following injury, thus likely acting 
as facultative progenitor cells and initiating a 
replicative program leading to exocrine tissue 
repair (reviewed in [1,39,40]). This de-
differentiation of adult pancreatic acinar cells is a 
critical process within the regenerative 
mechanism, as bona fide resident stem cells 
have not been reported in the adult pancreas 
(reviewed in [39]). Our results showed that, 
differently from what has been observed in other 
cell types and tissues [6,33,41-46], 5-HT does 
not act as a strong mitogen for acinar cells, as 
acinar replication was unchanged in vivo in the 
absence of 5-HT following 60% pancreatectomy 
and T3 stimulation and in vitro in AR42J acinar 
cells treated with 5-HT (data not shown). 
However, 5-HT is required for acinar de-
differentiation following inflammatory-mediated 
tissue damage. In this context, it is important to 
mention that 60% pancreatectomy is 
characterized by a moderate level of acinar cell 
de-differentiation and replication compared with 
the more robust regeneration observed during 
induction of pancreatitis. These observations 
support the notion that, according to the type and 
extent of tissue injury, the mammalian pancreas 
has the ability to trigger different regenerative 
mechanisms, which are driven by activation of a 
progenitor-like program or by a simple, clonal 
proliferation of differentiated acinar cells 
(reviewed in [39,47]). Furthermore, as progenitor-
based and clonal modalities of regeneration are 
not mutually exclusive and are likely to co-exist, 
the clonal regeneration independent from 
zymogen secretion is likely to account for the 
replication observed in Tph1
-/- 
mice with 
compromised progenitor-based regeneration. 
A major challenge undertaken in our study was to 
elucidate the mechanisms by which 5-HT affects 
acinar de-differentiation and ADM formation. We 
identified 5-HT-dependent secretion of zymogen 
content as one of the step promoting up-
regulation of progenitor-like genes, suggesting 
that physical removal of zymogens via secretion 
has to occur to allow de-differentiation of adult 
acinar cells. However, additional mechanisms are 
likely to contribute to the observed delayed de-
differentiation and ADM formation in the absence 
of 5-HT. We found that reduced secretion in 
Tph1
-/- 
mice limits chemokine production and 
leukocyte infiltration in the early stages of 
cerulein-induced pancreatitis ([10] and this work). 
Thus, it is possible that the few infiltrating 
leukocytes released a limited amount of pro-
inflammatory cytokines that may not have been 
sufficient to stimulate acinar de-differentiation 
and ADM formation. Indeed, Tph1
-/- 
mice had 
reduced levels of Tnf and MMP, both factors 
critical to induce ADM formation [28]. The 
comparable de-differentiation observed in vivo in 
isolated acini supports the hypothesis that the 5-
HT effect is not acinar cell autonomous but is 
mediated by macrophage-stimulated extracellular 
matrix digestion. However, it has to be noted that, 
despite sharing phenotypic similarities, the in 
vitro acinar de-differentiation may not completely 
reflect the molecular mechanisms occurring in 
the in vivo de-differentiation upon pancreatitis 
induction. Indeed, the process of acinar isolation 
per se activates Ras and its down-stream 
effectors ERK and AKT [29], the activity of which 
promotes cell de-differentiation. Thus, it is 
possible that the in vitro procedure bypasses a 
cell autonomous, 5-HT-mediated process 
occurring in vivo. In support of this hypothesis, 5-
HT has been reported to act upstream Ras-
dependent ERK1/2 activation via binding to 
different 5-HT receptors [48-50]. 
In this regard, an alternative explanation for the 
aberrant progenitor-based regeneration observed 
in Tph1
-/- 
mice is that 5-HT directly stimulates the 
expression of progenitor genes via 5-HT receptor 
signaling or intracellular mechanisms following its 
uptake. We found that type 1 and 2 5-HT 
receptors were up-regulated during pancreatic 
regeneration, following both pancreatitis and 
PPX. Of note, type-1 5-HT receptors were 
recently described to promote proliferation of 
human pancreatic cancer cells [34]. Finally, we 
also discovered an activation of the Hes1-Ptf1a 
axis in the uninjured pancreas.  Both under in 
vivo and in vitro experimental conditions, Hes1 
up-regulation was accompanied by down-
regulation of Ptf1a expression. This suggests the 
presence of a tightly regulated control of Ptf1 
expression by Hes1 in the adult pancreas, 
reminiscent of the embryonic situation. Hence, 
our data are in support of a dual role of Hes1 in 
the pathophysiology of the pancreas. In 
physiological situations, increased zymogen 
secretion is associated with moderate Hes1 up-
regulation, which limits Ptf1a expression and thus 
contributes to acinar homeostasis by preventing 
excessive zymogen expression. In pathological 
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situations that trigger acinar replication, a higher 
Hes1 up-regulation occurs with a consequent 
reduction of transcription factors and proteins 
required to maintain acinar function. This down-
regulation of differentiation genes may provide 
the cells with the suitable environment to up-
regulate a broader set of progenitor genes, 
leading to a robust acinar proliferation and organ 
repair. Collectively, these results indicate that 
expression of progenitor genes is not a 
synchronous event. Therefore, similarly to what 
was observed in the determination of diverse cell 
fates during development [51], the different time 
of expression of these transcription factors in the 
adult pancreas may reflect their distinctive 
function during homeostasis and regeneration.  
While highlighting the impact that 5-HT exerts on 
the de-differentiation and proliferation abilities of 
pancreatic cells under different regenerative 
conditions, this study nevertheless has some 
limitations. First, the use of a general Tph1 
knocked out model system precludes the 
dissection of the individual cell contribution in the 
synthesis of 5-HT. Serotonin is mainly produced 
by intestinal enterochromaffin cells and stored 
and released by circulating platelets. However, 
additional sources of serotonin exist, including 
nerve fibers, which are abundant in the 
pancreatic tissue, -cells [52] and even acinar 
cells [53].  In addition, further studies are 
necessary to characterize the role of the different 
5-HT receptors present on acinar and non-acinar 
cells to fully understand their contribution during 
pancreatic regeneration.  Finally, an aspect of the 
5-HT biology that has not been addressed in this 
study is a thorough characterization of vascular 
function. Disturbances in microcirculation, 
including vasoconstriction, are associated with 
acute pancreatitis (reviewed in [54]).  As 5-HT is 
a potent vasoconstrictor, it will be worth exploring 
whether alterations in the vascular biology 
contribute to the observed phenotype in Tph1
-/- 
mice.  
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Figures 
 
 
Figure 1. Lack of 5-HT results in defective acinar cell proliferation and delayed ADM formation. A. Quantification of replication 
markers expressed in pancreatic acinar cells showed increased number of Ki67 positive cells in Tph1
-/-
 mice after 7 and 14 days 
of pancreatitis.  B. Relative amount of acinar cells in G2 and M phases determined by pH3 staining pattern 7 and 14 days after 
pancreatitis induction. Data are expressed as percentage of the total number of pH3 positive cells with punctate (G2 phase) or 
complete nuclear staining (M phase). C. Hematoxylin-Eosin (H&E)-staining and ADM quantification showed lower amount of 
ADM (asterisks) in Tph1
-/-
 mice after three days of pancreatitis induction. Lower panels: enlarged views of insets three days after 
pancreatitis. Note the presence of mature ADM in WT mice characterized by loss of acinar content and tubular complex 
formation. Tph1
-/-
 pancreata presented sporadic de-regulation of acinar content (stars) without re-organization into tubular 
structures. D. Single plane confocal images showing nuclear localization of β-catenin in WT and Tph1
-/-
 pancreata three days 
after induction of pancreatitis. Nuclei are stained with DAPI (blue). E. Amylase and -catenin staining three days after induction 
of pancreatitis. Circled area and asterisk in WT pancreata represent ADM. Right panels: enlarged views of insets. Arrowhead, 
area with reduced amylase content and increased β-catenin expression in Tph1
-/-
 pancreata. Results are average ± SEM (n=5), 
*p<0.05. Scale bars: 50 µm 
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Figure 2.  Lack of 5-HT delays acinar de-differentiation during pancreatitis. A. Cytokeratin 19 (Ck19), Sox9,-catenin and 
amylase staining three and seven days after induction of pancreatitis. Nuclei in the IF pictures are stained with DAPI (blue).  B. 
qPCR of ductal and progenitor markers during the indicated times of cerulein-induced pancreatitis showed delayed expression 
in Tph1
-/-
 pancreata. Results are average ± SEM (n=5), *p<0.05. Scale bars: 50 m. 
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Figure 3. Lack of 5-HT prevents loss of amylase during pancreatitis. Biochemical determination of amylase activity (A) and 
immunoblotting of 10 µg of proteins (B) showed down-regulation of amylase in pancreatic tissue of WT but not Tph1
-/-
 mice one 
day after cerulein treatment. C. Immunostaining of amylase during 14 days of pancreatitis induction showed decreased protein 
expression in WT but not in Tph1
-/-
 mice one day after cerulein treatment. D. Electron micrographs of WT and Tph1
-/-
 pancreata. 
Note the close proximity of zymogen granules with reduced inter-granule space in Tph1
-/-
 mice, both in control and cerulein 
treatment. L, acinar lumen with evident microvilli. V, zymogen granule, M, mitochondrion. RER, rough endoplasmic reticulum. 
Right panel, quantification of the area occupied by granules expressed as percentage of total area. E. Size distribution of 
zymogen vesicle diameter. Note the higher abundance of vesicles with large diameter in Tph1
-/-
 mice following pancreatitis 
induction. Results are average ± SEM (n=5), *p<0.05. Scale bars: 1 m. 
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Figure 4. A. Scheme depicting the combined regimen with 5-HTP and cerulein (Cer). 0.9% NaCl was used as vehicle control. 
Circles indicate days of treatment starting from the first cerulein injection and triangles indicate days of animal harvest. Pan-
leukocyte immunostaining with anti-coronin 1 (B) and qPCR of pro-inflammatory chemokine MCP-1 (C) showed lower 
inflammation upon 5-HTP supplementation one day after induction of pancreatitis. Serum (D) and tissue (E) levels of amylase 8 
hours after pancreatitis induction following 5-HTP supplementation. qPCR of Hes1 (F) and immunostaining of Sox9 (G) one day 
after pancreatitis induction following 5-HTP supplementation. H. inflammatory cell quantification after PU.1 immunostaining 
showed reduced infiltration in Tph1
-/-
 mice three days after pancreatitis induction. I. qPCR of type1 and 2 macrophage markers 
three days after pancreatitis induction. J. qPCR of matrix metalloproteinase 7 (Mmp7) at the indicated days of pancreatitis 
induction. K. qPCR of progenitor and zymogen markers in isolated acini (inset) cultured for 24 hours in suspension to induce 
differentiation. 5-HT was added to the medium at 20 M concentration. Results are average ± SEM (n=5), *p<0.05. Scale bars: 
50 m. 
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Figure 5. Lack of 5-HT does not alter clonal regeneration of acinar cells following 60% pancreatectomy (PPX) and thyroid 
hormone T3 stimulation. A. Quantification of replication markers expressed in pancreatic acinar cells at the indicated times after 
partial pancreatectomy. B. Immunostaining of Ki67 at the indicated time points following PPX. Pictures represent an inset (1:10) 
of the original images used for Ki67 quantification. C. qPCR of progenitor-cell markers at the indicated times after PPX.  Note 
that WT but not Tph1
-/-
 mice increased Hes1 expression 14 days after surgery. Expression levels obtained in WT mice after 
cerulein induced pancreatitis (WT CIP) are shown as a comparison. D. Immunostaining of amylase showed comparable protein 
content  in WT and Tph1
-/-
 mice following PPX. E. Quantification of Ki67 expressed in pancreatic acinar cells following T3 
administration for six days. F. Pan-leukocyte immunostaining with anti-coronin1 showed comparable level of inflammatory cells 
in control and treated mice. Results are average ± SEM (n=3-5), *p<0.05. Scale bars: 50 m. 
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Figure 6. Increased zymogen secretion stimulates Hes1 expression in the uninjured pancreas. A. Left panel, immunostaining of 
Sox9 following 5-HTP supplementation showed nuclear expression of the protein in interstitial and centro-acinar cells but not in 
acinar cells. Right panel: qPCR analysis showed comparable levels of Sox9 transcripts in control and 5-HTP-treated pancreata. 
B. qPCR analysis showed Hes1 up-regulation and Ptf1a down-regulation in mouse pancreata following 5-HTP treatment. C. 
qPCR of Ptf1a and Hes1 expression in WT and Tph1
-/-
 mice in the early phases after pancreatitis induction. Dexamethasone 
treatment of pancreatic acinar AR42J cells for 48 hours increased cellular content of amylase (D) and reduced Sox9 expression 
at both transcript (left panel) and protein (right panel) levels (E), indicative of increased cellular differentiation. F. qPCR analysis 
showed a time-dependent increase of Hes1 a decrease of Ptf1a expression in dexamethasone-treated cells. Results are 
average ± SEM (n=5), *p<0.05. Scale bars: 50 µm. 
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Supplementary Online Materials  
Materials and Methods 
Biochemical reagents 
Unless otherwise stated, all chemicals were purchased from Sigma and cell culture reagents from 
Gibco-BRL. Stock solution for 5-HTP and cerulein were made in NaCl, dexamethasone in F-12K 
medium. 
Pancreatitis induction 
Animals received six hourly injections of 50 µg/kg cerulein on Monday, Wednesday and Friday and 
were harvested on Tuesday after one set of injections (day 1), on Thursday after two sets of injections 
(day 3) or on Monday after three (day 7) or six (day 14) sets of injections, without receiving cerulein 
treatment on the same day. 
 Pancreatic cell culture 
Pancreatic acini were isolated from WT and Tph1
-/-
 mice was performed as previously described in 
[55]. Cells de-differentiaion was induced according to [56] by culturing isolated acini in suspension for 
24 hours in RPMI 1640 glutamax medium supplemented with 10% fetal bovine serum, 50 U/mL 
penicillin, 50 µg/mL streptomycin, 0.1 mg/ml soybean trypsin inhibitor. 20µM 5-hydroxytryptamine 
creatinine sulfate complex (Sigma-Aldrich, Buchs, Switzerland) or PBS as vehicle control was added 
to the medium. 
AR42J cells were maintained in Kaighn’s modified Ham’s F-12 medium with 20% fetal bovine serum 
(FBS), 50 U/mL penicillin, and 50 µg/mL streptomycin at 37°C in a 5% CO2 atmosphere. Differentiation 
was induced by incubating adherent cells with 50 nM dexamethasone.  
Biochemical analysis of amylase activity 
For determination of amylase levels present in the serum, blood was sampled by heart puncture. For 
determination of amylase levels present in pancreatic tissue, pancreata were homogenized with RIPA 
buffer containing protease inhibitor cocktail (complete ultra-tablets mini, Roche Diagnostics, 
Mannheim, Germany). Amylase activity was measured using the Fuji Dri-Chem 4000i analyzer 
(Glattbrugg, Switzerland).  
Immunohistochemistry 
Pancreas specimens were embedded in paraffin for histological analyses as described [57]. For 
immunofluorescence analysis of cultured cell lines, AR42J cells were fixed in 3.6% formaldehyde and 
permeabilized with 0.2% Triton X-100 in PBS.  Primary antibodies used in this study were: rabbit anti-
phospho-histone 3 (Millipore, Massachusetts, USA), rabbit anti-sox9 (Millipore, Massachusetts, USA), 
rabbit anti-cyclin E (Abcam, Cambridge, UK), rabbit anti-coronin 1 (gift from Jean Pieters), rabbit anti-
amylase (Sigma-Aldrich, Buchs, Switzerland), rabbit anti Ki67 (Abcam, Cambridge, UK), rabbit anti-
p62/SQSTM1 (MBL, Massachusetts, USA), rabbit anti-β-catenin (Cell Signaling, Danvers, USA), rabbit 
anti-PU.1 (Cell Signaling, Danvers, USA), mouse anti-αSMA (Dako, Glostrup, Denmark), goat anti-
amylase (Santa Cruz Biotechnology, California). Secondary antibodies used in this study were: 
Biotinylated Goat Anti-Rabbit IgG (H+L). This antibody is included in the VECTASTAIN
®
 ABC kits, 
AlexaFluor 594, Goat Anti-Rabbit IgG (Life Technologies, Carlsbad, California, USA), FITC anti-goat 
(AdB Serotec, Germany), FITC anti-mouse (AdB Serotec, Germany). Nuclei were visualized with 4′, 6-
diamidino-2-phenylindole (DAPI).  Detection of proliferating cells in s-phase was performed with 
Invitrogen BrdU Staining Kit (Life Technologies, Carlsbad, California, USA). Detection of DNA 
fragmentation in apoptotic cells was performed with a TUNEL assay using an ApopTag peroxidase Kit 
(MP Biomedicals, Illkirch, France). Microscopy analyses were performed on a Nikon Eclipse Ti 
fluorescence microscope (Amsterdam, The Netherlands) or on a Leica SP2 AOBS confocal laser-
scanning microscope (Leica Microsystems, Wetzlar, Germany), using the appropriate settings. Image 
stacks of optical sections were further processed using the Huygens deconvolution software package 
version 2.7 (Scientific Volume Imaging, Hilversum, NL).  
 
Western blotting 
Immunoblotting was performed by homogenizing tissue samples in RIPA buffer containing protease 
inhibitor cocktail (Roche Diagnostics, Mannheim, Germany). Protein concentrations were determined 
using a Bradford protein assay (BioRad, Hercules, CA, USA). Aliquots corresponding to 10 µg of 
proteins were separated by SDS-PAGE electrophoresis. Blotting and chemiluminescent detection of 
immunoreactive bands were performed using the V3 Western Workflow system (BioRad, Hercules, 
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CA, USA), according to the manufacturer protocols. Primary antibodies rabbit anti-amylase (Sigma-
Aldrich, Buchs, Switzerland), rabbit anti-LC3B (Cell Signaling, Danvers, USA), and rabbit anti GAPDH 
(Sigma-Aldrich, Buchs, Switzerland) were incubated overnight at 4
o
C.  
Transcript analysis 
The following Taqman probes (Applied Biosystems) were used: Sox9 Mm00448840_m1, Hes1 
Mm01342805_m1, Notch-1 Mm00435249_m1, Mist1 (Bhlhb8) Mm00487695_m1, Cpa1 
Mm01137017_m1, MCP1/CCL2 Mm00441242_m1, PTF1a Mm00479622_m1, Amy 
Mm00651524_m1, Aldh1a1 Mm00657317_m1, Hnf1b Mm00447459_m1, Hnf6 (ONECUT1) 
Mm00839394_m1, Ck19 Mm00492980_m1, Cckbr Mm00432329_m1, CD146 (Mcam) 
Mm00522397_m1, Htr1a Mm00434106_s1, Htr1b Mm00439377_s1, Htr2a Mm00555764_m1, Htr2b 
Mm00434123_m1, SERT (Slc6a4) Mm00439391_m1, Mao A Mm00558004_m1, Mgl1 (Clec 10a) 
Mm00546124_m1, Nos2 Mm00440502_m1, Mrc1 (MMR, Clec 13D) Mm00485148_m1, Mmp7 
Mm00487724_m1, Pdx1 Mm00435565_m1, VEGFα Mm00437304_m1, IL-1β Mm00434228_m1, IL-6 
Mm00446190_m1, Tnfα Mm00443258_m1, Amy2 Rn00821330_g1, Ptf1a Rn00588645_m1, Hes1 
Rn00577566_m1, Sox9 Rn01751069_m1,TaqMan Ribosomal RNA Cont Reagents VIC (18S).  
Statistical analyses 
Groups of 5-6 animals were tested for each experiment. The data are expressed as the means ± SEM. 
The statistical significance of differences in the means of experimental groups was determined using 
an unpaired, two-tailed Student's t test unless otherwise stated. A p value < 0.05 was considered to be 
significant.  
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Figures 
 
  
 
 
Figure S1. A. Immunostaining of Ki67, 5-bromo-2'-deoxyuridine (BrdU) and phospho-histone 3 (pH3) at the indicated time 
points following cerulein treatment. Pictures represent an inset (1:10) of the original images used for quantification of positive 
cell number. B. Acinar cells (Ac) positive for Ki67 were identified by large and round nuclei located inside the acinar periphery, 
while interstitial cells (Int) had smaller and elongated nuclei present outside the pancreatic acini. PU.1 staining confirmed that 
part of interstitial cells with elongated nuclei was of inflammatory origin. Limited Ki67-smooth muscle actin (Sma) co-staining 
showed that interstitial activated stellate cells were not highly replicative both in WT and Tph1
-/-
 mice. Scale bars: 50 m.  
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Figure S2.-catenin, Sox9 and smooth muscle actin (Sma) immunostaining 7 days after induction of pancreatitis. Nuclei are 
stained with DAPI (blue).  Scale bars: 50 m. 
 
 
 
 
 
 
 
Figure S3. qPCR of genes typical of the differentiated state showed similar expression in the two strains 8 hours after cerulein 
treatment. Cpa1, carboxypeptidase 1. Results are average ± SEM (n=5). 
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Figure S4. A. Immunoblotting and quantification of processed LC3 (LC3-II) one day after cerulein treatment. Data are 
expressed as percentage of total LC3 (I+II). Results are average ± SEM (n=4). B. Immunostaining of the autophagic marker p62 
at the indicated time points following cerulein treatment. C. Quantification of p62 positive areas one day after cerulein treatment. 
Data are expressed as percentage of the pancreatic area in the field. Scale bars: 50 m. 
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Figure S5. A. Scheme depicting the treatment regimen with 5-HTP and cerulein (Cer). 0.9% NaCl was used as vehicle control. 
B.  Quantification of the replication markers Ki67 and pH3 expressed in pancreatic acinar (Ac) and interstitial (Int) cells after 
three days of 5-HTP supplementation and pancreatitis induction. C. Quantification of PU.1 expressing cells infiltrating the 
pancreas after three days of 5-HTP supplementation and pancreatitis induction. D. qPCR of acinar, ductal and progenitor 
markers after three days of 5-HTP supplementation and pancreatitis induction. E. qPCR of inflammation markers after three 
days of 5-HTP supplementation and pancreatitis induction. F. qPCR of inflammation and fibrosis markers after 14 days of 5-HTP 
supplementation and pancreatitis induction. G. Quantification of the replication marker Ki67 expressed in pancreatic acinar cells 
after 14 days of 5-HTP supplementation and pancreatitis induction. H. Quantification of ADM lesions after 14 days of 5-HTP 
supplementation and pancreatitis induction. I. Quantification of PU.1 expressing cells infiltrating the pancreas 14 days of 5-HTP 
supplementation and pancreatitis induction. Results are average ± SEM (n=5), *p<0.05. 
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Figure S6. A. PU.1 immunostaining in WT and Tph1
-/-
 pancreata three days after pancreatitis induction. B. qPCR of 
macrophage markers during the course of pancreatitis induction. C. qPCR of Tnf during the course of pancreatitis induction. D. 
qPCR of vascular related factors during the course of pancreatitis induction. Results are average ± SEM (n=5), *p<0.05. Scale 
bars: 50 m. 
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Figure S7. A. Pan-leukocyte immunostaining with anti-coronin-1 antibody two weeks after PPX. B TUNEL staining showed 
comparable number of apoptotic cells in intact acini in both strains at the indicated times following PPX. C. Sirius red staining 
showed comparable collagen deposition in the two strains two weeks after PPX. Scale bars: 50 m. 
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Figure S8. A. qPCR of 5-HT receptors and transporter in WT and Tph1
-/-
 pancreata during the course of pancreatitis. B. qPCR 
of 5-HT receptors and transporter one day after pancreatitis induction in WT, Tph1
-/-
 and WT mice supplemented with 5-HTP. C. 
qPCR of 5-HT receptors and transporter in WT and Tph1
-/-
 pancreata following pancreatectomy. D. qPCR of 5-HT receptors and 
transporter and 5-HT deaminase enzyme monoaminooxidase A (MaoA) in acini isolated from WT and Tph1
-/-
 mice one day after 
pancreatitis induction 
. 
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Figure S9. A. Bright field images of AR42J cells incubated for 2 days with dexamethasone. Note as the cells change 
morphology upon treatment. B. Quantification of AR42J cell number following 48 hours incubation with 50 nM dexamethasone 
(Dexa). Results are average ± SEM (n=3). 
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7. Discussion 
 
5-HT has been recognized for decades as an important signaling molecule both in neuronal 
and non-neuronal processes, but its potential is possibly greater than ever expected. Novel 
emerging roles are constantly ascribed to 5-HT both in physiological and pathological 
conditions and, surprisingly, new intracellular mechanisms of action are now attributed to this 
multifunctional bioactive amine.  
 
7.1 The role of 5-HT in cell secretion  
The serotonergic network plays in fact a central role in nearly all cell types with an active 
secretory process. The term “network” has not been chosen accidentally: an increasing 
number of studies reports that the manipulation of one or more components related to the 5-
HT system significantly alter the secretory activity both in a positive and a negative manner. 
One of the best characterized examples in this sense are the mammary glands, which are 
influenced by 5-HT not only during development and homeostasis, but also substantially 
during lactation and the following glandular involution state. Of note, the initiating event for 
secretory activation requires cytoskeletal remodeling in which tight junctions assemble to 
ensure tissue integrity. During pregnancy and lactation, a physiological period in which 
mammary cells suffer a massive stress due to elevated protein synthesis and secretion, the 
hormone prolactin induces a significant increase of Tph1 mRNA levels in the glands. This 
increased gene expression reflects the local 5-HT production, which negatively controls milk 
production and secretion. Experiments using the Tph1-/- mouse model showed that 5-HT-
deficient mice are hyper-responsive to prolactin and consequently secrete earlier and more 
abundantly milk compared to the wild type dames. The opposite outcome is obtained after 
interfering with 5-HT clearance, both by inhibiting SERT-mediated uptake and MAO activity. 
In this case milk production is prematurely interrupted and the glandular remodeling is 
significantly impaired leading to an involution-like state [66]. It is now proposed that 5-HT 
regulates mammary gland secretion according to a paracrine signaling pathway: the locally 
produced 5-HT accumulates in the interstitial fluid surrounding the glands and activates the 
5-HT7 receptors localized on the epithelial mammary cells. 5-HT7 intracellular signaling 
negatively regulates milk protein synthesis and induces the disruption of tight junctions 
allowing glandular involution [67].  
Epithelial mammary cells, similar to pancreatic β-cells described before in this thesis (chapter 
3.6), constitute the perfect example of highly secretory cells responsive to physiological 
hormonal changes that require the entire 5-HT network to control their morphology and 
activities. Importantly, in both cases a cell-autonomous regulation it has been identified 
totally independent both from neuronal and platelet-derived 5-HT signaling. 
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Exocrine cells, situated in different body locations, share many similarities in terms of 
development, polarity and functions [68] and it wouldn’t be surprising if they would share 
certain regulatory mechanisms. 
Pancreatic exocrine acinar cells have been intensively investigated during the last decades 
and 5-HT was found to modulate zymogen secretion upon a receptor-mediated neuronal 
signaling. However, the possibility that non-neuronal 5-HT could regulate the secretion of 
these cells was not addressed so far.  
In order to investigate this hypothesis, our group took advantage of a general Tph1-/- mouse 
model depleted of peripheral 5-HT but unaffected in the central nervous system. These 
animals do not show any pancreatic abnormalities. However, when we closer analyzed 
isolated acinar cells, we noticed that unstimulated Tph1-/- acini contained more zymogen 
positive granules compared to the WT acini. Further ultrastructural analysis with electron 
microscopy on pancreatic tissue confirmed that zymogen granules did not differ in terms of 
size within the strains but rather they were numerically more abundant and tightly packed in 
Tph1-/- mice. In addition, utilizing freshly isolated acini, currently considered a valid ex vivo 
experimental approach to investigate secretory mechanisms [69],  we found that while basal 
secretion was comparable in the two strains, Tph1-/- acini secreted less zymogens when 
stimulated both at physiological and supramaximal concentration of the secretagogue 
cerulein. On the other hand, we also observed a block of both basal and cerulein-induced 
secretion when the rat acinar cell line AR42J was pre-incubated with a highly selective SERT 
inhibitor (fluoxetine), and with different antagonists of 5-HT receptor subtypes. To our 
surprise, SERT inhibition completely abolished the baso-lateral blebs-formation induced by 
actin cytoskeletal remodeling following supramaximal doses of cerulein [59]. Hence, our 
results indicate that 5-HT is required for the correct basal and stimulated secretion, possibly 
regulating cytoskeletal dynamics.  
Given the central role of acinar cell secretion in the etiopathogenesis of acute pancreatitis, 
and supported by the evidence that 5-HT is involved in zymogen secretion, we explored the 
possibility that 5-HT modulates granule dynamics also in vivo in a pathological context, 
treating WT and Tph1-/- mice with high doses of cerulein. Cerulein administration represents 
the best model for clinical interstitial acute pancreatitis and it induces aberrant acinar 
secretion with consequent zymogen release into the interstitial space and eventually in the 
blood circulation. Eight hours after cerulein stimulation, we found a significant reduction of 
amylase in the Tph1-/- animal serum, symptom of a reduced interstitial zymogen secretion. 
Also in this case electron microscopy helped us to clarify how granules distribute upon 
stimulation. In both strains cerulein triggered a general enlargement of granule size, 
indicative of granule swelling preceding content expulsion. However, Tph1-/- granules were 
more packed, more abundant and bigger compared to the WT, presumably as a 
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consequence of impaired secretion and not due to zymogen synthesis. When we analyzed 
the cytoskeletal reorganization, known to be the driving mechanism for cell secretion [59-61], 
we observed a lack of baso-lateral actin re-organization and a different GTPase Rac1 
localization. 
Finally, in Tph1-/- animals the impairment of the secretory process led to a different onset and 
progression of the inflammatory phase. While in WT animals, 24 hours after the initiation of 
tissue insult, elevated levels of circulating zymogens were still detectable in blood and a clear 
immune response characterized the site of injury, in Tph1-/- animals blood parameters were 
found in baseline levels and the pancreatic tissue was nearly devoid of inflammation. Thus, 
our data strongly support the hypothesis that 5-HT-dependent ectopic secretion is needed for 
the initiation of pancreatitis.  
Further interesting results were obtained when both animal strains were supplemented with 
5-hydroxytryptophan (5-HTP), the precursor molecule converted into 5-HT. While in Tph1-/- 
animals 5-HTP supplementation, as expected, restored all the early hallmarks of pancreatitis, 
including elevated blood amylase and local inflammation, in WT animals the 5-HTP 
significantly attenuated the inflammatory phase. 
5-HTP was recently found to stimulate, in a dose-dependent manner, acinar cell apical 
secretion and thus it has been associated with a protective effect during the initiation of acute 
pancreatitis [70]. Also in our experimental conditions, WT mice pre-treated with 5-HTP, 
displayed lower levels of inflammatory infiltrates, chemokine expression and serum amylase 
upon cerulein stimulation, presumably as a consequence of increased zymogen apical 
secretion into the duct thus counteracting the aberrant baso-lateral one. 
 
7.2 The role of 5-HT in inflammation 
There is now abundant evidence to suggest that 5-HT modulates the immune response and, 
in particular, inflammatory diseases. When injury occurs, mast cells and platelets release 
their 5-HT content, which in turn recruits and activates immune cells at the site of damage. 
Neutrophils, eosinophils, monocytes, macrophages, dendritic cells (DCs), mast cells and 
natural killer cells (NK) express a variety of 5-HT receptors. For some of these cell types, 
such as monocyte, macrophages and mast cells, the expression of SERT has been reported 
[71]. While the role of 5-HT uptake remains ambiguous and yet to be addressed, 5-HT 
receptor signaling is well known to work as an important modulator of chemotaxis and 
cytokine production. Inhibitors of 5-HT receptor class 1 and 2A, as well as agonists for 
receptor class 2B, 3 and 7 significantly attenuate several types of experimentally-induced 
inflammation, not only in the gut, but also in the liver and lungs. Additionally lack or 
irreversible inhibition of Tph1 enzyme delays and reduces the severity of different types of 
experimental colitis (reviewed in [72]).  
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Therefore, although our data strongly support the evidence that 5-HT modulates acinar cell 
secretion, we cannot exclude the possibility that other mechanisms, such as modulation of 
inflammation, may occur in Tph1-/- mice. In fact, eight hours from the first cerulein injection, a 
moderate serum amylase was detectable in Tph1-/- mice indicating that, even if reduced, 
ectopic secretion was taking place also in these mice. In this context, one would expect a 
reduced inflammatory cell influx into the tissue, but this was not the case as Tph1-/- mice that 
did not present any noticeable sign of inflammation in the pancreas after 24 hours of cerulein 
administration. Interestingly, also 5-HTP supplementation was associated with different 
inflammatory responses. Early 5-HTP supplementation in WT animals, prevented the onset 
of pancreatitis, while 2 weeks 5-HTP exposure, in combination with cerulein administration, 
culminated into a more severe local inflammation. The possible explanation for this dual 
effect may lie in 5-HTP metabolism. 5-HTP is quickly converted to 5-HT, which can be further 
metabolized in melatonin. Both 5-HTP and melatonin possess potent anti-inflammatory 
properties [73-75] and thus it cannot be excluded that during the early phase of pancreatitis, 
excess of 5-HTP, or a possible increase of melatonin, may be responsible for the observed 
anti-inflammatory effect. On the other hand, prolonged exposure to 5-HTP was associated to 
a more severe inflammation, possibly due to a preferential conversion of 5-HTP into 5-HT, 
well known for its pro-inflammatory properties. Future analysis on 5-HTP and its metabolites 
are necessary to better understand their role during the course of pancreatitis. 
Hence, briefly summarizing what has been discussed so far, we could conclude that the 5-
HT network is indispensable for patho-physiological zymogen secretion of acinar cells and 
that it modulates the immune response during the progression of pancreatitis. It remains now 
to be further discussed whether 5-HT influences also the tissue regeneration.  
 
7.3 The role of 5-HT in tissue regeneration 
5-HT has been considered for a long time a potent mitogenic factor and evidence of this role 
was observed in liver regeneration following hepatectomy, megakaryocyte colony formation,  
pulmonary artery smooth muscle cell proliferation and, as aforementioned, β cell expansion 
during pregnancy [44, 76-78]. 
In case of the adult pancreas, the mitogenic role of 5-HT in exocrine acinar cell proliferation 
and self-renewal was never addressed before. For the first time we reported that 5-HT does 
not mediate acinar cell proliferation in the absence of a strong inflammatory scenario. In fact, 
cell proliferation was not affected in Tph1-/- mice following 60% pancreatectomy, where mild 
inflammation is normally observed at the resection margin but not in the intact tissue. 
Corroborating data, in this sense, was obtained by supplementing both WT and Tph1-/- with 
the thyroid hormone T3, known to have a potent mitogenic effect on the pancreas [79]. Also 
in this case, lack of 5-HT did not interfere with cell proliferation, which was rather comparable 
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in the two strains, indicating that acinar cells, if not injured, are able to proliferate also in the 
absence of peripheral 5-HT. 
Conversely, we discovered that peripheral 5-HT is instead critical in the context of cerulein-
induced acinar injury and development of pancreatitis. Recent studies suggest that acinar 
cells may act as facultative progenitors capable of reverting to embryonic-like cells under 
injury conditions associated with inflammation. During this reprogramming phase, a complete 
down-regulation of acinar-specific genes is observed, in favor of the up-regulation of 
progenitor and ductal markers, such as Sox9 and CK19. Afterwards, a morphological 
remodeling of the acinar architecture to the duct-like structures, named ADMs, appears in the 
tissue. In WT animals, this process is transient and resolves in a relative short time, together 
with the overall morphology and functionality of the injured organ. In contrast, in Tph1-/- 
animals, all the mentioned consecutive steps resulted rather delayed and aberrant. Similarly 
to WT, the mutant mice displayed a prompt down-regulation of acinar-specific genes but this 
was not followed by acinar cell zymogen emptying as observed in the WT cells. Thus, the 
subsequent up-regulation of ductal markers as well as the appearance of ADMs was 
postponed in the mutant mice concomitant with the delayed onset of inflammation. 
Furthermore, it is important to remark that only the secretory process but not zymogen 
synthesis or their activation was compromised in Tph1-/- mice. Therefore, when the harmful 
cargo was finally secreted, it probably culminated into a more severe and sustained 
inflammation compared to WT mice. This hypothesis is supported by the exceptional up-
regulation of macrophage markers accompanied with more abundant acinar cell proliferation 
and ADM formation in Tph1-/- mice. Therefore, our experimental approaches support the 
correlation between acinar trans-differentiation and the type of tissue injury, which confirms 
the pivotal role of the local activation of innate cells.  
To conclude, the physical removal of intracellular digestive zymogens, via a 5-HT dependent 
secretion, constitutes one of the early but fundamental processes initiating the cascade of 
events characterizing the onset of pancreatitis. 
 
8. Mouse model limitations 
The mouse model utilized in our experimental studies revealed a significant role of 5-HT in 
the etiopathogenesis of pancreatitis. However, this has several limitations.  
Firstly, a general tph1 knocked out system is unsuitable to define which cell type constitutes 
the main source of 5-HT production to guarantee pancreatic acinar cell secretion. Secondly, 
lack of tph1 but not tph2 implies the possibility that a certain undefined amount of 5-HT is 
locally released by enteric neuronal cells, thus our system was not completely devoid of 5-
HT. Neuronal 5-HT stimulus, for instance, would explain why a reduced acinar cell secretion 
was still observed in vivo but not ex vivo in Tph1-/- mice. Finally, as extensively discussed in 
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this thesis, the three main processes observed during the course of pancreatitis, namely cell 
secretion, tissue inflammation and acinar cell regeneration, are directly and indirectly linked 
with the 5-HT network. Therefore, modulation of cell specific 5-HT synthesis, receptor 
signaling, intracellular uptake, biochemical precursor availability and metabolism is needed to 
elucidate the role of 5-HT in each cell type taking part to the process.  
 
9. Future investigations 
Adult acinar cells acquire plastic characteristics losing their cellular identity in response to 
inflammation-mediated injury. This instability creates a window where a cell can either be 
redirected into a differentiated state, or undergo deregulated neoplasia in the presence of 
oncogene expression. ADMs represent the critical step influencing these two fates. During 
the recovery phase of acute pancreatitis, ADMs represent a pool of cells with exceptional 
plasticity required for tissue regeneration. 
For a long time acinar cells were suspected to actively contribute to pancreatic 
tumorigenesis, but a definitive confirmation derives from recent lineage-tracing studies 
showing that persistent ADM lesions may lead to pre-malignant pancreatic lesions [80].  
Noteworthy, ADM transition depends on cytoskeletal remodeling of acinar cells, but the 
molecular mechanisms regulating this process are not completely elucidated. In the last few 
years the small GTPase Rac1 was shown to be responsible for the cytoskeletal 
rearrangements necessary for ADM formation. Specifically, activation of Rac1 drives the re-
localization of actin filaments from the apical to the baso-lateral side of trans-differentiating 
acinar cells, a sign for loss of cell polarity [81]. Importantly, this actin remodeling is similar to 
the one found to induce the aberrant baso-lateral zymogen secretion typically observed upon 
supramaximal stimulation with cerulein [59]. Finally, Rac1 was also identified as a proto-
oncogene responsible for pancreatic ductal adenocarcinoma (PDAC) progression due to its 
involvement in promoting cell motility and metastasis [82, 83]. Our group demonstrated that 
5-HT regulates zymogen secretion of pancreatic acinar cells following cerulein-induced 
pancreatitis, influences actin relocalization during the acute phase of the disease, and it is 
fundamental for ADM formation during the recovery phase.  
Based on multiple evidence indicating that 5-HT influences several processes otherwise 
attributable to Rac1, we intend now to investigate whether a functional correlation within 
these two molecules occurs during ADM formation. Rac1 belongs to the Rho family of small 
G proteins, a subgroup of the Ras superfamily and regulates a variety of cellular processes, 
such as cytoskeletal organization, vesicular transport, cell cycle progression, cell adhesion 
and migration, neuronal differentiation, and several enzymatic activities [84, 85]. Rac1 
functions depend on a cycle of molecular switch between two conformational states: a GTP-
bound, active state and a GDP-bound, inactive state. The GTP/GDP cycling is controlled by 
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many regulatory molecules, such as GTPase activating proteins (GAPs), guanine nucleotide 
exchange factors (GEFs) and GDP dissociation inhibitors (GDIs) [86]. A number of post-
translation modifications are also found both in the regulator-interaction sites and in the GTP-
hydrolyzing domain greatly affecting the GTPase activation cycle. One of the possible 
modifications consists in the transamidation of primary amines on the glutamine residues of 
GTPases. 5-HT constitutes one of the intracellular sources of amines. Transglutaminases 
mediate the cross-linking reaction between the amine and protein residues and the resulting 
modification is named serotonylation. Moreover, this mechanism depends on the SERT-
mediated 5-HT uptake in conjunction with Ca2+ mobilization. Notably, Rac1 activity was 
demonstrated to be transiently increased due to TGase-mediated serotonylation of Rac1 via 
stimulation of 5-HT2A receptors (reviewed in [18, 87]). 
 
10. Preliminary results 
 
10.1 Acinar cells uptake 5-HT via SERT 
As described in the previous paragraph, SERT-mediated 5-HT uptake is necessary to 
modulate GTPases activity, implying the important role of intracellular 5-HT in this 
mechanism. Before investigating whether 5-HT modulates the activity of GTPases, it was 
fundamental to prove that a SERT-mediated 5-HT uptake occurs also in pancreatic acinar 
cells. For this reason, an [3H]-5-hydroxytryptamine-uptake assay was performed both in 
freshly isolated murine acinar cells and in rat AR42J cell line. Two independent experiments, 
in both cellular systems, clearly indicated that acinar cells are able to uptake 5-HT via an 
active transport mechanism and that this transport is significantly reduced by fluoxetine, a 
highly specific SERT inhibitor (Fig.6). 
 
 
 
 
 
Figure 6. Fluoxetine prevents 5-HT uptake in pancreatic acinar cells. The time-course was performed at 37°C in presence or 
absence of 20µM FL and at 0°C to determine non-specific uptake. Note the significant 5-HT uptake inhibition at 37°C (active 
transport) in presence of fluoxetine (FL). 
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10.2 SERT inhibition prevents Rac1 activation in vitro 
Given that serotonylation increases the activity of Rac1, we took advantage of an elegant 
FRET-based assay to test whether limiting the intracellular 5-HT availability decreased Rac1 
activation.  
Five independent experiments performed on the AR42J cell line demonstrated that inhibition 
of SERT with fluoxetine was sufficient to prevent Rac1 activation (Fig.7), suggesting that 
reducing intracellular levels of 5-HT has the potential to inhibit the activity of proteins that are 
targets of serotonylation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Inhibition of 5-HT uptake prevents Rac1 activation. Left panel, time course quantification of Rac1 activation in 
presence of the SERT inhibitor fluoxetine (black columns), as determined by FRET assay. FRET was performed using the donor 
recovery after acceptor photo-bleaching method using the FRET-AB wizard of the Leica software. Acceptor (yellow fluorescent 
protein) fluorescence was bleached at 100% laser intensity. Right panel, schematic representation of the used construct and 
representative confocal image. 
 
 
10.3 SERT inhibition prevents ADM formation in vitro 
Given that ADM formation is tightly dependent on cytoskeletal rearrangements driven by the 
activation of Rac1 and that Rac1 activity is reduced in vitro upon SERT inhibition with 
fluoxetine, we tested whether fluoxetine treatment prevented Rac1-driven ADM formation in 
a 3D culture system. Pancreatic explants from mice harboring the KrasG12D mutation, 
sufficient to induce ADM formation both in vivo and in 3D culture [88], were used for this 
purpose. Rac1 inhibitor (iRac1) was used as a positive control, while TG inhibitor 
(cysteamine, Cys) was used to test whether TG-dependent serotonylation occurred during 
ADM formation. Cys and iRac1 significantly reduced ADM formation, but fluoxetine treatment 
completely prevented their appearance (Fig.8). 
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Figure 8. Inhibition of Rac1, TG and 5-HT uptake inhibits ADM formation in 3D cultures of pancreatic explants. Explants were 
embedded in collagen, treated with the SERT inhibitor fluoxetine (FL, red columns) and the number of ADM quantified after one 
and two days of culture. Right panel, representative images of acinar clusters (Day0) and ADM (Day 2). 
 
 
Collectively, these data suggest that 5-HT promotes cytoskeletal remodeling underlying the 
formation of ADM lesions. Present and future work aim to investigate whether inhibition of 5-
HT uptake affects ADM formation in a pancreatic cancer model and thus might represent a 
valid therapeutic approach to prevent spreading of pre-malignant lesions.  
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